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Abstract 
Quality of life studies in Duchenne Muscular Dystrophy are scarce. This study explores the 
relationship between the broad concept of quality of life and the more focused concept of 
health-related quality of life and examines the relationships between patient and family 
characteristics and health-related quality of life. Participants were recruited from the 
Canadian Neuromuscular Disease Registry, 98 parents and 85 children completed the Quality 
of My Life and Pediatric Quality of Life Inventory questionnaires. Simple regression was 
used to examine the relationship between quality of life and health-related quality of life. 
Multivariable linear regressions were used to determine child and family characteristics 
associated with health-related quality of life outcomes. Higher levels of subjective fatigue 
and use of wheelchair emerged as factors most consistently associated with lower levels 
health-related quality of life. Interventions to reduce fatigue could lead to improvement of 
health-related quality of life for children with Duchenne Muscular Dystrophy. 
Keywords 
Duchenne muscular dystrophy, health-related quality of life, quality of life, cross-sectional 
study, registry, parent proxy, child self, multivariable regression, fatigue 
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Chapter 1  
      Introduction and Research Objectives 1
 
1.1 Overview of thesis 
Duchenne Muscular Dystrophy (DMD) is a progressive, chronic neuromuscular disorder, 
affecting 1 in 5,000 boys. It is characterized by gradual loss of muscle strength resulting 
in profound physical disability and premature death. Due to the life-limiting and chronic 
nature of this disease, maximizing quality of life in these children is of the utmost 
importance. This thesis aims to provide a comprehensive description of quality of life and 
health-related quality of life in children with DMD from the children’s and parents’ 
perspectives. Furthermore, the relationship between the broader concept of quality of life 
and the narrower concept of health-related quality of life is investigated. Finally, this 
thesis explores the clinical and demographic factors associated with quality of life and 
health-related quality of life in children with DMD. 
1.2 Background 
1.2.1 Quality of life and health-related quality of life in children with 
chronic illnesses 
Advances in medicine have expanded the focus of healthcare from extending life to also 
include improving quality of life. The World Health Organization Quality of Life group 
has defined quality of life as an ‘individual’s perception of their position in life, in the 
context of culture and value systems in which they live and in relation to their goals, 
expectations, standards, and concerns’ (“The World Health Organization quality of life 
assessment (WHOQOL),” 1995). Health-related quality of life (HRQOL) narrows the 
scope of quality of life (QOL) and focuses specifically on the impact of illness and 
treatments on a person’s life (De Civita et al., 2005; Guyatt et al., 1993; Spieth & Harris, 
1996). HRQOL does not pertain to aspects of life such as environmental quality and 
political stability (Guyatt et al., 1993; Taylor et al., 2008), which are important, but 
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cannot be influenced by healthcare intervention. The primary focus of this thesis is on 
HRQOL, with one component aimed at distinguishing and exploring the relationship 
between QOL and HRQOL. Although there has not been a complete consensus on the 
operational definition of HRQOL, two recurrent characteristics that underlie most 
measurements of HRQOL have emerged: they are subjective and multidimensional 
(Matza et al., 2004). Subjectivity refers to the fact that HRQOL measures patient’s own 
perception of their health or life, in contrast with objective clinical measures such as 
blood pressure; multidimensionality refers to measurement of HRQOL from multiple 
aspects of a person’s life, for example, the physical, psychological and social aspects.  
Rationale for studying HRQOL in children with chronic illnesses 
As survival rates and life expectancy for many childhood illnesses increase, improvement 
in quality of life for these children becomes increasingly important. The rationale for 
studying HRQOL in children with chronic illnesses is manifold. First, HRQOL is an 
important component of outcome assessment and provides information not captured by 
traditional clinical measures. More often, patient-reported outcomes such as HRQOL are 
being recognized as important  end-points of clinical trials in conjunction with traditional 
clinical measures (Drotar, 2004; Eiser & Morse, 2001a). Apart from clinical trials, 
HRQOL measures may also be used to evaluate the success of interventions and services 
in clinical settings (Eiser & Morse, 2001a). Second, while traditional medical care tends 
to rely on physiological measurements such as blood pressure, there are evidence that 
these measures are not always of the most importance to patients (Guyatt et al., 1993; 
Ronen et al., 2011). Furthermore, physiological measures do not necessarily correlate 
well with subjective well-being. Two patients who exhibit the same physical symptoms 
may have very different subjective experiences (Eiser & Morse, 2001a; Guyatt et al., 
1993).Thus, management of physical symptoms is no longer sufficient in the treatment of 
a chronic illness. HRQOL studies allow researchers and clinicians to elucidate the 
determinants of HRQOL, identify risk factors for poor HRQOL, and ultimately improve 
HRQOL, which some have argued is the ultimate goal of managing chronic illnesses 
(Eiser & Morse, 2001b; Payot & Barrington, 2011). 
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Considerations in assessing QOL and HRQOL in children 
There are a number of conceptual and methodological considerations when studying 
childhood QOL and HRQOL. Three of these considerations: the distinction between 
quality of life and health-related quality of life; the existence of generic and disease-
specific measures, and the existence of child and parent reports, are discussed below. 
 Quality of life and health-related quality of life 
Quality of life and health-related quality of life are terms that are often used 
interchangeably, but in fact represent different concepts. A systematic review of 
paediatric QOL and HRQOL measures (Davis et al., 2006) identified eleven different 
definitions of QOL and HRQOL across fourteen generic and 25 disease specific 
measures. Although it is recognized that there should be distinction between QOL and 
HRQOL, few studies have empirically differentiated these two concepts (Davis et al., 
2006; De Civita et al., 2005; Eiser & Morse, 2001a; Gill & Feinstein, 1994; Guyatt et al., 
1993; Ronen et al., 2011). It has been suggested that two global ratings, one for overall 
QOL, and one for HRQOL be used (Gill & Feinstein, 1994). Despite these 
recommendations, to our knowledge, there is only one example in paediatric patients 
where the distinction between QOL and HRQOL has been examined. Feldman et al. 
(2000) designed the Quality of My Life (QoML) questionnaire to ask children and their 
parents to rate the child’s ‘overall’ quality of life (QOL) and their quality of life 
‘considering my health’ (HRQOL) and found that both children and their parents 
differentiated between these two constructs, and that HRQOL only explained 30% of the 
variability in QOL. This was done in a sample of children being treated for rheumatoid 
arthritis. Thus, there exist empirical support for the distinction between QOL and 
HRQOL.  
Another reason for examining the relationship between QOL and HRQOL is the notion 
of ‘disability paradox’, which is the phenomenon whereby people with disabilities report 
good or excellent QOL, when external observers might assume they have quite poor QOL 
(Albrecht & Devlieger, 1999). As part of the development of the QoML measure, 
Feldman et al. (2000) conducted qualitative debriefing with children and parents, many 
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of whom reported that health contributed only in small part to overall QOL. People may 
attach different weights to the various aspects they deem to contribute to their QOL. 
Therefore it is possible for someone to have good or excellent QOL despite poorer 
HRQOL and it is reasonable to assume that the relationship between the two may change 
at different stages of disease progression. Determining the factors that contribute to QOL 
beyond HRQOL is especially important to patients with DMD, where physical 
deterioration is inevitable but a good QOL may be achievable.  
 Generic and disease-specific measures 
HRQOL measures can be divided into generic and disease-specific. Generic measures are 
applicable across different disease populations and thus are often used to compare of 
HRQOL in groups with various diseases and to those in the general population. Disease-
specific questionnaires include items that are pertinent to a particular condition. 
Compared to generic measures, disease-specific measures have greater sensitivity and 
specificity, and are better at detecting treatment effects and changes across time (Eiser & 
Morse, 2001a; Quittner et al., 2003; Spieth & Harris, 1996), however, they do not allow 
for comparison to other disease groups or to a general population. Therefore, it has been 
recommended that both disease–specific and generic measures be used in a 
complementary fashion (Spieth & Harris, 1996).  
Child self-reports and parent proxy-reports 
Assessing QOL and HRQOL in children has its unique challenges. Children were once 
considered incapable of reliably reporting their own QOL or HRQOL out of concerns 
they were not cognitively able to understand measures of QOL or HRQOL, and parent-
proxy measures were used instead (Eiser & Morse, 2001c; Quittner et al., 2003). 
However, it has since been recognized that children, like adults, are the best informants 
on their own subjective experiences and should report their own QOL and HRQOL 
whenever possible. There are evidence supporting the reliability and validity of children’s 
report of their health state (Drotar, 2004). Children as young as five have been found able 
to reliably report their HRQOL (Varni et al., 2007a). Furthermore, parents may not 
always be able to accurately interpret their children’s emotional state or be able to 
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directly observe their social interactions (Quittner et al., 2003). On the other hand, in 
situations where the child is too young, sick or cognitively impaired to report their QOL 
and HRQOL, parent-proxy measures need to be used. In addition, parent reports are still 
important because of parents’ influence on healthcare decisions for their children 
(Palermo et al., 2008). Both child and parent perspectives offer unique information and 
thus it has been recommended that QOL and HRQOL be collected from multiple 
informants (Drotar, 2004; Eiser & Morse, 2001d; Palermo et al., 2008). 
1.2.2 Duchenne Muscular Dystrophy 
Genetics and pathology 
Duchenne Muscular Dystrophy (DMD) is the most common and severe form of 
childhood muscular dystrophy. It is the result of mutations in the dystrophin gene, located 
on the X-chromosome (Hoffman et al., 1988). Due to the X-linked mode of inheritance, 
almost all affected individuals are male. The incidence for DMD is estimated to be in the 
range of 1 in 3600-6000 live-born male infants (Emery, 1991). A retrospective study 
carried out in Nova Scotia found that the incidence of DMD has remained stable between 
the years of 1969 and 2008 (Dooley et al., 2010). 
Dystrophin proteins are thought to play a structural role in muscle cell membrane, 
maintaining its integrity. Absence of dystrophin results in muscle cells being more prone 
to damage from mechanical stress (Deconinck & Dan, 2007; McDonald et al., 1995). In 
DMD patients, skeletal muscles are affected at birth, but most boys do not show 
symptoms of the disease until they are between 3 to 5 years of age. With increasing 
availability and efficiency of molecular technology, genetic testing has become the gold 
standard diagnostic tool (Bushby et al., 2010a).  
Clinical features 
Progressive muscle weakness 
Proximal, lower extremity muscles are the first to show signs of degeneration. As muscle 
deterioration progresses, the boys lose ambulation. Age of loss ambulation has 
historically been between the ages of 7 to 12 (Biggar, 2006; Brooke et al., 1989). Loss of 
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ambulation happens rapidly, over the span of a few weeks to a few months. By mid-teens, 
almost all boys are in wheelchairs. As the disease progresses, the affected individual 
becomes gradually weaker in the upper limbs, eventually losing the ability to perform 
daily activities. It has been thought that there are two ‘plateaus’ in the progression of 
DMD: the period between diagnosis and loss of ambulation and the period from loss of 
ambulation to significant cardio and respiratory compromises. During these plateau 
phases, the health of the child with DMD can remain relatively stable.  
Throughout the progression of DMD, initial diagnosis and loss of ambulation are perhaps 
the two most life-altering events faced by the affected child and his family. Parents report 
that they are overwhelmed and devastated by the diagnosis of DMD in their child (Green 
& Murton, 1996), often more so than the children themselves. Parents have also reported 
experiencing increased stress and emotional upheaval around the time their son loses 
ambulation (Bothwell et al., 2002; Bray et al., 2011; Erby et al., 2006). However, as with 
any other major stress, families adjust to it (McCubbin & McCubbin, 1993). The periods 
immediately after diagnosis and after loss of ambulation may be particularly vulnerable 
times for the child and his family and warrant closer scrutiny. 
Orthopedic complications 
One of the most concerning complications related to DMD is the development of 
scoliosis. Various studies have reported that between 74% and 100% of DMD subjects 
develop scoliosis (Muntoni et al., 2006). In addition to causing discomfort, scoliosis 
further impedes respiratory function, which is already compromised in DMD patients. 
Bone fractures are common, occurring in 21% to 44% of boys (Kornberg & Yiu, 2008). 
Some patients have lost mobility permanently due to bone fractures (McDonald et al., 
2002). Taken together, these complications indicate bone health of boys with DMD is 
compromised, and may have serious impact on their quality of life.   
Pulmonary function decline 
Boys with DMD begin to experience respiratory problems between the ages of 9 and 11 
years due to loss of respiratory muscle strength. Respiratory insufficiency first manifests 
during sleep, boys with DMD may experience sleep apnea, decreased quality of sleep or 
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frequent wakening throughout the night (Polat et al., 2012).  Along with muscular 
deterioration, vital capacity further decreases. Eventually, all boys require assisted 
ventilation, usually in the form of nocturnal bilevel positive airway pressure (BiPAP) to 
support their breathing (Biggar, 2006).   
Cardiomyopathy 
Cardiac muscles are affected in DMD patients. Cardiomyopathies may often be 
subclinical in younger boys due to the boys’ lack of strenuous activities and thus low 
demand placed on the heart. However, as cardiac muscles weakens further, the likelihood 
of symptomatic cardiomyopathies increases. One study reports that clinically apparent 
cardiac problems are present in one-third of DMD patients by 14 years of age, and 
present in all patients over 18 years of age (Nigro et al., 1990).  
Cognitive delay and psychological functioning 
The prevalence of intellectual disability in the Duchenne population is higher in the 
general population. Dystrophin is expressed in the central nervous system in a number of 
different isoforms, regulated by different promoters (Mehler, 2000). There is evidence 
that mutations in specific regulatory regions in these brain isoforms are linked with 
mental retardation (Bardoni et al., 2000).  There is also evidence of increased likelihood 
of being diagnosed with a developmental disorder such as attention deficit hyperactivity 
disorder or autism (Hendriksen & Vles, 2008). While boys with DMD are more likely to 
exhibit cognitive and psychosocial deficits, there is still great variability within this 
population. The extent of heterogeneity in intellectual and psychological deficits is 
greater than in motor deficits in boys with DMD. 
Survival 
The most common cause of death for Duchenne patients is respiratory failure, followed 
by heart failure (Finsterer, 2006). As with many other diseases, improvement in medical 
technology and quality of care has increased survival in DMD patients. The mean life 
expectancy has increased from 14 years of age in the 1960s to 25 years of age in the 
1990s (Eagle et al., 2002; Passamano et al., 2012).  
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Treatment and Care 
Glucocorticoids 
There is no cure for Duchenne muscular dystrophy. The most commonly prescribed 
medications are glucocorticoids, which have become the standard of practice in treating 
DMD. Long term cohort studies have shown that glucocorticoids can prolong ambulation 
for up to five years (Moxley et al., 2010). While glucocorticoids have obvious benefits, 
they also have serious side-effects. one of the most common side-effects is weight gain, 
and it can lead adverse health consequences such as increased incidence of sleep apnea 
and increased burden on the respiratory system (McMillan et al., 2010). Other adverse 
effects include increase risk of fracture, growth retardation, delayed puberty, behavioral 
changes, and immune suppression (Ay et al., 2009; Bushby et al., 2010a; Moxley et al., 
2010).  
Multidisciplinary care 
Due to the multi-systemic nature of the disease, it has been recommended that children 
with DMD be followed up in multidisciplinary clinics where comprehensive care can be 
provided by a variety of specialists (Bushby et al., 2010b). In Canada, paediatric 
neuromuscular clinics exist across the country and care teams are composed of 
neurologists, respirologists, physical therapists and other health care professionals 
(McMillan et al., 2010).  Patients visit clinics every 6 to 12 months, and in addition to 
receiving management of muscle deterioration, are monitored routinely for orthopedic, 
respiratory and cardiac abnormalities so that complications can be managed as they arise.  
DMD patients experience gradual loss of respiratory muscle, resulting in hypoventilation, 
particularly during sleep. Non-invasive positive pressure assisted ventilation is normally 
the first step in providing respiratory support to DMD patients (McMillan et al., 2010). 
Cardiac function is monitored regularly via electrocardiogram and echocardiogram. 
Dilated cardiomyopathies are treated with angiotensin converting enzyme inhibitors and 
beta-blockers (Bushby et al., 2010b; Finsterer, 2006).  
While pharmaceutical and technological interventions have improved quantity and 
quality of life for Duchenne patients over the past few decades, the disease remains a 
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relentlessly progressive one that is devastating for the affected child and his family. In the 
past decade, with the advancement of molecular techniques, many therapies that show 
promise in the treatment of DMD have emerged. As more of these therapies undergo 
clinical trials, proper assessment of trial outcomes is crucial. 
1.3 Objectives 
The literature assessing QOL and HRQOL in children with DMD is scarce. The available 
studies have several limitations that will be discussed in more detail in the next chapter. 
Briefly, many of these studies have small sample sizes, uses only parent-reported 
HRQOL and draw samples from a single clinic. Furthermore, almost all studies are 
descriptive, and do not examine potential determinants of HRQOL.  
There is a need for a more comprehensive examination of QOL and HRQOL in children 
with DMD from both children’s and parents’ perspectives, using general and disease-
specific measures. Examining the relationship between QOL and HRQOL will allow us 
to gain a better understanding of the role health plays in overall QOL. Exploring factors 
that are associated with HRQOL would allow us to identify potential determinants of 
HRQOL that could contribute to improvement of HRQOL. With these gaps of knowledge 
in mind, the objectives of this thesis are: 
 
1. Describe the QOL and HRQOL in a sample of boys with DMD in Canada from both 
children’s and parents’ perspectives. 
 
2. Examine the relationship between QOL and HRQOL.  
Hypothesis: QOL and HRQOL will be rated as distinct but related concepts by boys 
with DMD and their parents.  
 
3. Explore child and family characteristics that contribute to any difference between 
QOL and HRQOL. 
Hypothesis: Family characteristics relating to social economic status will be 
associated with the difference between QOL and HRQOL. 
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4. Explore associations of child and family characteristics with multidimensional 
measures of HRQOL.  
Hypothesis: Age and ambulation status will be associated with the physical 
component and the total component of a multidimensional measure of HRQOL; 
family stress will be significantly associated with the psychosocial component of 
multidimensional HRQOL. 
  
5. Compare QOL and HRQOL of ambulant boys who were diagnosed recently to those 
who were diagnosed longer ago. 
Hypothesis: For boys who are still ambulant, those who have been diagnosed before 
2012 will have better QOL and HRQOL than those who have been diagnosed after 
2012. 
 
6. Compare QOL and HRQOL of boys who have lost ambulation recently to those who 
lost ambulation longer ago.  
Hypothesis: For boys who are non-ambulant, those who lost ambulation before 2012 
will have better QOL and HRQOL than those who lost ambulation after 2012.  
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Chapter 2  
                          Literature Review 2
 
2.1 Methodology of Literature Review 
A literature search was conducted in January 2014 in the electronic databases MEDLINE, 
EMBASE and PsychINFO. Using the following key words: 1) Duchenne Muscular 
Dystrophy; 2) quality of life OR health related quality of life OR health-related quality of 
life OR health status..; 3) pediatri* OR paediatri OR teenage* OR adolescent OR child 
OR child* 4) 1 AND 2 AND 3. Medical Subject Heading (MeSH) terms were used 
whenever possible.  The references of relevant studies were used to identify potential 
other studies not discovered upon initial search.  
Inclusion criteria 
Studies were considered for inclusion if: 1) child or parent-reported QOL or HRQOL was 
the main outcome of the study; 2) study population was specific to or included children 
with Duchenne Muscular Dystrophy (≤18); and 3) were published in the English 
language.   
2.2 Results 
2.2.1 Overview of studies 
Nineteen studies were identified that fit the inclusion criteria. The studies were published 
between 2005 and 2013 and were conducted in the following countries: United States, the 
Netherlands, Germany, China, Brazil, France, Australia, Italy, and Canada.  Thirteen 
measures of QOL or HRQOL were used; a summary of these instruments can be found in 
Table 2.1. The majority of the generic instruments used are multidimensional, consisting 
at least of physical, emotional and social domains, including: KIDSCREEN-52, 
DISABKIDS, Pediatric Quality of Life Generic Core 4.0 (PedsQL), Child Health 
Questionnaire-parent report (CHQ), Vecu Sante Percu par l’adolescdent (VSP-A). Some 
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studies used instruments that examine an individual domain of HRQOL. For example, the 
Personal Adjustment and Roles Scale-III (PARS-III) focuses only on psychological 
adjustment and does not include questions pertaining to physical functioning. One of the 
challenges of summarizing studies is the diversity of the instruments used. There is 
heterogeneity among the instruments in their purpose and design. For example, all 
instruments have unique domains, and some have no summary score. This makes it hard 
to compare results across studies. However, the most commonly used instruments, the 
PedsQL Generic Core 4.0 and the CHQ-50 Parent Report both have summary physical 
and psychosocial scores, making them most comparable to one another.   
Seventeen of the studies were cross-sectional and two were longitudinal, conducted over 
the span of nine months and one year. Many studies (N= 8) had single-centre designs and 
recruited participants through approaching patients in neuromuscular clinics. The sample 
sizes of the studies ranged from 25 to 287. It should be noted, however, that some of 
studies’ patient populations included adults with DMD or children with other types of 
neuromuscular disorders (Grootenhuis et al., 2007; Mah et al., 2008; Orcesi et al., 2014; 
Vuillerot et al., 2010).   
Although almost all of the studies of HRQOL in children with DMD are descriptive, 
some comparative analyses were completed.  Four recurring themes were identified 
among the studies: 1) comparison of HRQOL between boys with DMD and either a 
healthy control group or a group with another chronic illness; 2) comparison between 
sub-groups within the paediatric DMD sample; 3) investigation of relationship between 
clinical measures of function and child or parent reported HRQOL; 4) and comparison 
and agreement between child self-report HRQOL and parent reported HRQOL. Each of 
the four themes will be discussed in detail below. A summary of major findings of all 
studies can be found in Table 2.2. 
Comparison to healthy peers or those with another illness 
Ten studies compared HRQOL in boys with DMD to a healthy cohort, or children with 
other chronic illnesses. Four of these studies (Bendixen et al., 2012; Henricson et al., 
2013; McDonald et al., 2010; Orcesi et al., 2014) recruited healthy controls along with 
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their DMD sample, six studies used established normative data from the literature as their 
healthy controls (Baiardini et al., 2011; Bray et al., 2011; Davis et al., 2010; Elsenbruch 
et al., 2013; Opstal et al., 2013; Uzark et al., 2012). 
Eight studies found that boys with DMD had significantly poorer physical HRQOL than 
healthy boys and children with other types of chronic illnesses. Five studies reported that 
boys with DMD had significantly lower psychosocial score than healthy controls 
(Baiardini et al., 2011; Bendixen et al., 2012; Bray et al., 2011; Davis et al., 2010; C. M. 
McDonald et al., 2010). None of the studies reported effect sizes, but the differences in 
physical HRQOL score were consistently larger than differences in psychosocial score. 
Houwen-van Opstal et al. (2013) reported that there were no significant differences in 
HRQOL score between boys with DMD and healthy children, in any of the ten domains 
of the KIDSCREEN-52, except the physical domain. Elsenbruch and colleagues (2013) 
divided their sample into child and adolescent groups. In the children’s group, all 
subscale scores as well as the total HRQOL score were significantly lower than the scores 
of age-matched children with other chronic illnesses (p<0.05). In the adolescent group, 
only the social inclusion subdomain score was significantly lower in boys with DMD 
compared to normative data (p<0.01). Orcesi et al. (2014) developed a new HRQOL 
instrument targeted at young children with neuromuscular illnesses, the Strips of Life 
with Emoticons (SOLE), which only has an overall score and no domains scores. 
Compared to healthy boys, the mean score for boys with DMD was significantly lower.  
Overall, compared to healthy children or children with other chronic illnesses, boys with 
DMD had significantly poorer HRQOL scores. This difference is most consistent in the 
physical domain. In eight out of ten studies, boys with DMD had lower physical HRQOL 
scores than healthy controls and children with other types of chronic illnesses, and this 
deficiency was observed in both child self and parent proxy reports. Most of the studies 
found that the psychosocial scores of boys with DMD are also lower than their healthy 
peers. 
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Comparison between subgroups 
DMD is a progressive disease with inevitable physical deterioration. Thus, a natural 
question is whether HRQOL declines with disease progression. This question would most 
ideally be addressed through longitudinal studies where a group of patients is followed 
over time. However, as HRQOL in DMD patients is a relatively new area of research, 
almost all studies are cross-sectional.  In cross-sectional studies, patients with different 
disease severity have been compared to one another. Age is often used as a proxy for 
disease progression given that generally, older children have more severe illness. Disease 
groups may also be separated by ambulation status (ambulant or non-ambulant) or 
ventilation status (does not require ventilation or requires ventilation).  
Ten studies compared HRQOL stratified by disease severity. The most commonly used 
questionnaire was the PedsQL Generic Core 4.0, which has three versions based on age: 
ages 5-7, ages 8-12, and ages 13-17.  In addition, the PedsQL inventory has disease 
specific modules, including Neuromuscular and DMD modules. Disease specific 
measures tend to be more sensitive when used to compare HRQOL across disease sub-
groups (Eiser & Morse, 2001c).  
Three studies used the PedsQL 4.0 Generic Core scale and reported that younger boys 
had significantly higher physical HRQOL score than older boys (Bray et al., 2010; 
McDonald et al., 2010; Uzark et al., 2012). In contrast, another study reported that in 
their sample of boys with DMD, those who were younger than 10 years of age did not 
report significantly higher physical HRQOL than those who were older (Bendixen et al., 
2012). Two studies reported boys who were using wheelchair had significantly lower 
physical domains scores than boys who were still ambulant (Baiardini et al., 2011; Davis 
et al., 2010).  
There is less consistency across studies that involve assessment of psychosocial HRQOL. 
Four studies reported that there were no significant differences between older and 
younger boys in psychosocial HRQOL scores (Baiardini et al., 2011; Bendixen et al., 
2012; Bray et al., 2011; McDonald et al., 2010). Similarly, Davis et al. (2010) reported 
that there were no significant differences in psychosocial HRQOL scores between 
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children who were using wheelchairs and those who were not. In contrast, Hendriksen et 
al. (2009) found that the psychosocial adjustment score was positively associated with 
age in a survey of parents of boys with DMD (p<0.001). As well, Uzark et al. (2012) 
found that children in the oldest age group reported significantly higher psychosocial 
score than children in younger age groups (p=0.05). Mah et al. (2008) surveyed the 
parents of 109 children with various neuromuscular disorders, 24 of whom had Duchenne 
or Becker Muscular Dystrophy, they found that children on ventilation support had 
significantly lower physical HRQOL (p<0.001) and psychosocial scores (p=0.028) 
compared to children not on ventilation.  
Kohler et al. (2005) found that in their group of DMD patients, those who were ventilated 
did not report a significantly lower physical or mental HRQOL scores than those who did 
not require ventilation.  However, the author used the Short Form-36, which was 
designed to assess HRQOL in adults rather than in children.  
In a longitudinal study, Simon et al. (2011) followed a group of Boys with DMD over 
nine months and administered the Life Satisfaction questionnaire every three months, for 
a total of four times. They divided their sample into four age groups, and found that life 
satisfaction scores improved significantly in most domains over the follow-up period for 
boys across all four age groups. However, the authors did not report the actual scores of 
each age group at each time point but instead reported the average score over four time 
points for each age group. This makes it difficult to confirm the conclusion these authors 
drew. One major limitation of the study was that the questionnaire used was designed for 
adolescents, but was used on children under 12 years of age, who made up majority of the 
study sample. There was no psychometric evaluation to justify this deviation. 
Overall, physical HRQOL in children who are at a more severe stage of the disease is 
worse than children who are at a less severe stage. Disease severity is proxied by age, and 
use of assistive devices such as wheelchairs and ventilation. Less consistent is the 
relationship between disease severity and psychosocial HRQOL. Some studies 
(Hendriksen et al., 2009; Uzark et al., 2012) found older children reported better 
psychosocial HRQOL despite having more severe disease, while others (Baiardini et al., 
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2011; Bendixen et al., 2012; Bray et al., 2011; McDonald et al., 2010) report there are no 
significant differences between older and younger children. However, it is worth noting 
that no conclusions can be drawn on any causal relationship between disease severity and 
HRQOL due to the cross-sectional nature of most studies. In addition, the studies have 
generally had small sample sizes precluding more robust analyses such as regression 
modeling to determine the relative contribution of these disease severity measures. 
Correlation with clinical measures 
Traditional outcome measurements used in clinical trials of DMD involve quantitative 
strength and function. With the increasing recognition of the importance of patient-
reported outcomes such as HRQOL, some studies have examined the relationship 
between clinical measures and HRQOL. There are two common groups of clinical 
measures: measurement of strength and measurement of motor function. 
The domains of the KIDSCREEN-52 (Opstal et al., 2013) and the DISABKIDS 
(Elsenbruch et al., 2013) did not correlate well with clinical measures. The only 
significant correlations were between the physical domain of the KIDSCREEN-52 and 
the Vignos scale, a measure of upper body strength (r=-0.45, p=0.01); and between 
emotional domain of the DISABKIDS and the Vignos scale (r=0.5, p=0.0490). 
McDonald et al. (2010) found that only the physical domains of the parent-reported 
PedsQL 4.0 Generic Core and the Paediatric Outcomes Data Collection Instrument 
(PODCI) significantly correlated with functional measures. Similarly, in two separate 
studies, Bray and colleagues (Bray et al., 2010, 2011) found that only the physical 
domains of the CHQ-50 parent report (r=-0.38, P=0.03) and the physical domain of the 
PedsQL correlated with the Vignos scale (r=-0.17; p=0.01). The 6-minute walk test is a 
recently adopted outcome measure in clinical trials of DMD (NCT01462292). Henricson 
et al. (2013) found that decline in 6-minute walk test over one year correlated 
significantly with decline in PODCI score. 
Vuillerot et al. (2010) examined well-being of a group of 43 adolescents with various 
neuromuscular disorders, 19 of whom were DMD patients. They concluded that HRQOL 
does not correlate with motor function.  
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Overall, it appears that while the physical domains of some HRQOL measures correlates 
significantly with commonly used clinical measures, neither the psychosocial domains 
nor the overall HRQOL scores correlated with clinical end points. the examination of the 
relationship between clinical measures and HRQOL is difficult challenging due to the 
variety of HRQOL measures and motor strength and function measures being used by 
investigators, reflecting the early and evolving nature of this area of research. 
Comparison and agreement between child report and parent report 
It has been well-recognized that assessment of both parent and child perspectives of a 
child’s HRQOL is important, as there are often discrepancies between them (De Civita et 
al., 2005; Eiser & Morse, 2001c).  
Parents generally rate their child’s HRQOL lower than children themselves did (Bray et 
al., 2010; Davis et al., 2010; Hu et al., 2013; Uzark et al., 2012), although no statistical 
comparisons were conducted in these studies. This difference tends to be greater in the 
psychosocial domains than the physical domain. Lim et al. (2014) and colleagues did find 
that parents reported significantly lower HRQOL on all domains of the PedsQL 4.0 
Generic Core than their sons.  
Eight studies included both child self-reports and parent proxy-reports, and of these, five 
studies examined concordance between child and parent reports. Parent and child 
concordance is determined by intraclass correlation coefficient (ICC). For the purposes of 
this review, an ICC of ≤ 0.40 would be considered poor, 0.41 to 0.75 would be 
considered moderate, and > 0.75 would be excellent (Uzark et al., 2012). 
In studies that used the PedsQL Generic Core 4.0 questionnaire  (Bray et al., 2010; Davis 
et al., 2010; Uzark et al., 2012), only the school domain had moderate concordance, while 
other domains had poor concordance. Davis et al. (2010) found that all subdomains of the 
English PedsQL 3.0 Neuromuscular have poor parent-child concordance. Hu et al. (2013) 
tested the Chinese version of the same questionnaire and found that for 50 child-parent 
pairs, the ICC of the overall score and subdomains were moderate.  Lim et al. (2014) 
found that by both classical test analysis, which examines scale-level agreement, and 
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Rasch analysis, which examines item-level agreement, there was better concordance 
between children and parents on the physical scale than psychosocial scale. 
Overall, parents tend to rate their child’s HRQOL as worse than children themselves do, 
and the concordance between parent and child is in the poor to moderate range with the 
majority of domains and total scores in the poor range. The more observable aspects of a 
child’s life, such as the school function tended to yield higher concordance. 
Discussion and limitations of previous studies 
The existing literature on HRQOL in boys with DMD offers some useful preliminary 
information, but, there are several limitations that must be taken into account in 
interpreting the findings. There is heterogeneity across studies with regards to the 
definition and constructs of QOL and HRQOL. Some measures focus only on 
individuals’ feelings about their well-being (PARS-III, LSI-A), while other instruments 
are closer to measures of health status in that the questions evaluate the extent of a 
problem has occurred (CHQ and PedsQL questionnaires). Furthermore, it is difficult to 
compare the results across measures that have different domains, particularly if they do 
not have summary score(s).  Fortunately, the most commonly used questionnaires are 
CHQ and PedsQL, both of which have physical and psychosocial summary scores, 
making it easier to compare the findings.   
Many of the studies used convenience sampling and drew participants from local 
clinic(s). Given the severity of the disease, it is reasonable to assume that almost all boys 
with DMD are managed at a tertiary-care clinic, thus patients recruited through such 
clinics are likely representative of the DMD population. However, most studies did not 
report a response rate and it is unclear whether the respondents differ from those who 
chose not to participate. Moreover, there has not been a previous study in Canada of boys 
with DMD. Due to the rarity of DMD, it is difficult to employ a population-based random 
sampling procedure. A registry based study may be an alternative to population based 
random sampling.  
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Most of the studies had relatively small sample sizes, with ten of the 18 studies having a 
sample size of 50 participants or less. When subgroup comparisons are made, the sample 
sizes became even smaller. Thus the lack of any significant differences in comparison 
could be due to insufficient power. Additionally, of all HRQOL measures, only the 
PedsQL questionnaires has been validated specifically in a paediatric DMD population    
(Davis et al., 2010). The reliability and validity of other measures in this population is 
unknown. Some studies have applied questionnaires designed for adults (Kohler et al., 
2005) or adolescents (Simon et al., 2011) to children, without any psychometric 
evaluation of their appropriateness. 
Many of the studies did not report their results comprehensively. Some reporting issues 
include lack of p-value being reported (Opstal et al., 2013), not computing a summary 
score despite one being available for the questionnaire used and displaying results in 
graphs with no error bars (Bray et al., 2010).  
In four of the studies (Grootenhuis et al., 2007; Mah et al., 2008; Orcesi et al., 2014; 
Vuillerot et al., 2010), boys with DMD were part of a sample that included children with 
other types of neuromuscular disorders, making it hard to elucidate specifically the 
HRQOL of boys with DMD. Some studies excluded boys younger than 8 years old 
(Davis et al., 2010; Elsenbruch et al., 2013), or boys who have lost ambulation 
(Henricson et al., 2013; McDonald et al., 2010). The time around initial diagnosis and 
loss of ambulation, may be particularly vulnerable times for boys with DMD and should 
receive more focus. Finally, not all of the studies assessed HRQOL from both parent and 
child perspectives, and only three studies used disease-specific questionnaires (Davis et 
al., 2010; Hu et al., 2013; Uzark et al., 2012). 
A multitude of QOL and HRQOL measures were used. Most studies that used the 
PedsQL questionnaires designated it as a measure of HRQOL, two studies designated it 
as QOL (Bendixen et al., 2012; Mah et al., 2008). The KIDSCREEN-52, DISABKIDS, 
PODCI and TACQoL were considered as HRQOL measures; while the VSPA, LSI-A, 
Short Form-36 and SOLE were considered to be QOL measures. The CHQ-50 was 
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considered to be a QOL measure by one study (Baiardini et al., 2011) and health status by 
another study (Bray et al., 2011). 
2.2.2 Conclusions 
From the existing literature, it is apparent that the HRQOL of boys with DMD is poorer 
than that of their healthy peers, particularly in the physical domain. Within the DMD 
sample, boys with more severe disease consistently reported poorer physical HRQOL 
than boys with less severe disease; such a difference was not as consistent for 
psychosocial HRQOL. Similarly, while the physical domains of HRQOL instruments 
correlated well with clinical measures of functioning, psychosocial domains did not. 
Finally, the parent and child concordance for most measures of HRQOL was poor. It is 
important to determine whether these findings can be replicated in future studies that 
overcome some of the shortcomings of previous work. A comprehensive study that 
examines QOL and HRQOL from children’s and parents’ perspectives, using validated 
generic and disease specific questionnaires and one that spans the entire paediatric DMD 
age range would help researchers and clinicians gain more insight into the subjective 
well-being of children with DMD. Furthermore, determining child or family factors that 
are associated with HRQOL could help clinicians and researchers identify potential risk 
factors for poor HRQOL and provide appropriate intervention. 
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Table 2-1 Summary of quality of life and health-related quality of life instruments 
used by studies reviewed 
Instrument Dimensions/domains Scoring Studies   
KIDSCREEN-52 
 
Dutch version 
Physical, psychological, moods/emotions, 
self-perception, autonomy, parent 
relations/home life, financial resources, 
social support/peers, school 
environment, social acceptance. 
Scores on ten 
domains 
 
No total score 
(Opstal et al., 
2013) 
DISABKIDS 
 
German version 
Independence, emotion, social inclusion, 
social exclusion, physical limitation, 
treatment 
Scores on ten 
domains and 
total score 
(Elsenbruch et al., 
2013) 
Pediatric 
Quality of Life 
4.0 Generic 
Core (PedsQL 
4.0 Generic) 
 
English and 
Chinese 
versions 
Physical, emotional, social and school 
functions 
Scores on four 
domains 
2 summary scores: 
Physical score; 
Psychosocial score 
(emotional, social 
and school functions 
combined)  
Total score 
(Davis et al., 
2010; Henricson 
et al., 2013; Hu et 
al., 2013; Mah et 
al., 2008; 
McDonald et al., 
2010; Uzark et al., 
2012) 
Paediatric 
Outcome Data 
Collection 
Instrument 
(PODCI) 
 
English 
Upper extremity, transfer/basic mobility, 
sports/physical function, pain, happiness, 
and global functioning 
Scores on five 
domains 
Global functioning 
score is mean of all 
domains excluding 
happiness. 
(McDonald et al., 
2010) 
TACQoL 
Dutch 
Motor functioning, physical symptoms, 
social functioning, cognitive functioning, 
positive emotions, negative emotions, 
autonomy 
Scores on seven 
domains 
No total score 
(Grootenhuis et 
al., 2007) 
Vecu Sante 
percu par 
l’adolescent 
(VSPA) 
 
French 
Vitality, leisure, relationship with parents, 
relationship with friends, relationship 
with teachers, body image, school 
performance, physical and psychological 
wellbeing 
Scores on 9 domains 
No total score 
(Vuillerot et al., 
2010) 
Child Health 
Questionnaire 
Parent Form 50 
(CHQ-50) 
 
English version 
Physical Functioning, Role/Social 
Limitations – Physical, 
General Health Perceptions, Bodily 
Pain/Discomfort, Family Activities, 
Role/Social Limitations – Emotional, 
Role/Social Limitations– Behavioral, 
Parent Impact Time, Parent Impact 
Emotion, Self-Esteem, Mental Health, 
Behavior, Family Cohesion, Change in 
health 
Scores on 15 
domains 
 
2 summary scores: 
physical and 
psychosocial 
 
No total score 
(Baiardini et al., 
2011; Bray et al., 
2011) 
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Personal 
Adjustment and 
roles Skills Scale 
(PARS-III) 
 
Dutch 
Peer relations, dependency, hostility, 
productivity, anxiety/depression, and 
withdrawal 
Scores on six 
domains 
 
No total score 
 
(Hendriksen et al., 
2009) 
Life Satisfaction 
Index for 
Adolescents 
(LSI-A) 
 
English and 
Dutch versions 
General wellbeing, interpersonal 
relationship, personal development, 
personal satisfaction, recreation 
Scores on five 
domains   
 
No total score 
(Simon et al., 
2011) 
Short Form 36 Vitality, physical functioning, bodily pain, 
general health perceptions, physical role 
functioning, emotional role functioning, 
social role functioning, mental health 
 
Scores on eight 
domains 
 
No total score 
(Kohler et al., 
2005) 
Strips of Life 
with Emoticons 
(SOLE) 
 
Italian 
33 individual items that assess how a 
child feels at different times in a typical 
day 
Total score of all 33 
items 
(Orcesi et al., 
2014) 
PedsQL 
Neuromuscular 
Module 
English and 
Chinese 
Versions 
About My Neuromuscular Disease, 
communication, About our family 
resources 
3 domain scores 
 
Total score 
(Davis et al., 
2010; Hu et al., 
2013) 
PedsQL DMD 
module 
 
English version 
Daily Activities, Treatment, Worry, 
communication 
4 domain scores 
 
No total score 
(Uzark et al., 
2012) 
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Table 2-2 Summary of studies reviewed 
Citation Study design and sample 
characteristics 
HRQOL measure used Major findings 
Baiardini et al., 2011 
 
Cross-sectional; 
DMD sample N=27, mean 
age 11.4  
 
Neuromuscular clinics in 
Italy 
Child Health Questionnaire 
50- Parent Form 
 
Parent-report 
Parents reported significantly lower 
physical, psychosocial score than 
normative sample 
 
Use of wheelchairs and ventilation were 
significantly associated with lower 
physical functioning HRQOL 
Bendixen et al., 2012 Cross-sectional; 
DMD sample N=50; mean 
age 8.0 years (range 5-17) 
healthy sample N=25 
 
Neuromuscular clinic in the 
United States (Florida) 
PedsQL 4.0 Generic Core  
 
Self- and  parent- report 
 
 
HRQOL was lower for boys with DMD in 
the physical, social and school domains, 
and the overall score. There was no 
significant difference in the emotional 
domain 
 
Participation level in physical and social 
activities is not correlated to HRQOL in 
boys with DMD. 
 
Older boys had significantly lower 
participation level, but not  HRQOL than 
younger boys 
Bray et al., 2010 Cross-sectional; 
DMD sample N=35, mean 
age 12.5 (range 9-17 
 
Recruited through 
neurogenetics clinics and 
community newsletters in 
Australia 
PedsQL 4.0 Generic Core 
 
Self- and parent- reports 
Parent-child concordance range from 
poor to modest in different domains, 
greatest in school domain 
 
Self-reported scores significantly 
correlated with physical domain and 
Vignos scale 
 
Younger boys with DMD had significantly 
higher physical domain score than older 
boys 
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Bray et al., 2011 Cross-sectional; 
DMD sample N=34, mean 
age 9.9 (range 5-18) 
 
Three urban paediatric 
hospitals in Australia 
 
Child Health Questionnaire 
50-Parent Form 
 
Parent-report 
Parents reported significantly lower 
physical, psychosocial score than 
normative sample and sample of children 
with Charcot-Marie-Tooth disease 
 
Parents experienced greatest stress 
during disease transition points such as 
loss of ambulation 
Davis et al., 2010 Cross-sectional; 
DMD sample N=44, mean 
age 12.9 (range 8-18) 
 
Neuromuscular clinics in the 
United States 
PedsQL 4.0 Generic Core 
and PedsQL 3.0 
Neuromuscular modules 
 
Self- and parent- reports 
Parent and child reported HRQOL 
significantly lower than normative 
sample  
 
The PedsQL 3.0 Neuromuscular module 
is reliable and valid measure of HRQOL in 
the paediatric DMD population 
 
Full time wheelchair users had lower 
physical HRQOL in both generic and 
neuromuscular specific modules 
Elsenbruch et al., 2013 Cross-sectional; 
DMD sample N=50, mean 
age 15.4 years (range 8-23) 
Control derived from 1,152 
children with different 
chronic health conditions 
 
Single paediatric neurology 
clinic in Germany 
DISABKIDS chronic generic 
module for children and 
adolescents; Short Form-36 
for young adults 
 
Self- and parent- report 
In children, HRQOL score of boys with 
DMD in all domains were lower than 
boys with other chronic illnesses. In 
adolescents, only social inclusion domain 
had lower score. 
 
No correlation between total HRQOL 
score and Vignos function score. 
 
Grootenhuis et al., 2007 
Cross-sectional 
Muscular dystrophy sample 
N=40, 36 are DMD patients 
mean age 12.6 (range 8-17) 
 
Dutch Neuromuscular 
centres 
TACQoL children for under 
16 year olds 
TACQoL adult for 16 and 
older 
 
Self-report 
Children and adolescents with muscular 
dystrophy reported significantly lower 
QOL in ‘motor functioning’ domain than 
healthy peers 
 
Better ‘physical symptoms’ score, but 
worse motor functioning score than 
healthy peers 
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Hendriksen et al., 2009 Cross-sectional  
DMD sample N=287, mean 
age 10.9 (range 5-18) 
 
 the Netherland and U.S 
Personal Adjustment and 
Role Skills Scale (PARS-III) 
 
 
Parent report 
The PARS-III is a reliable and valid 
measure in the paediatric DMD 
population 
 
PARS-III total score was not significantly 
different in DMD compared to males 
with other chronic medical conditions 
 
PARS-III total score positively correlated 
with increase in age  
Hu et al., 2013 Cross-sectional; 
DMD sample N=56 
Mean age 7.54 (range 2-13) 
 
Tertiary hospitals in urban 
China 
Chinese version of PedsQL 
4.0 Generic Core and 
Neuromuscular 3.0 module  
 
Self and parent-report 
The Chinese version of PedsQL 4.0 
General core and Neuromuscular is 
feasible, reliable and valid 
 
Agreement between parent and child is 
moderate. 
Henricson et al., 2013 Longitudinal  
DMD sample N=24 
ambulatory boys mean age 
7.9 (range 4-12) 
Controls N=36  
 
Neuromuscular clinics in the 
United States (California) 
PedsQL 4.0 Generic Core 
PODCI 
 
 
The 6-minute walk test and the PODCI 
global scale, and transfer scale declined 
significantly over one-year interval. 
 
One-year change in PODCI scores are 
significantly correlated with one-year 
change in 6 minute walk test 
Kohler et al., 2005 Cross-sectional 
DMD sample N=35  mean 
age 17 (range 8-33) 
 
Short Form-36 
 
Self-report 
Neither physical nor mental summary 
score in DMD patients was not found to 
be correlated with physical impairment 
or FVC 
Lim et al., 2014 Cross-sectional 
DMD sample N=63 parent-
child pairs 
Mean age 10.3 (range 5-16) 
 
United States 
PedsQL 4.0 Generic Core 
 
Self and parent-report 
Parents reported significantly lower 
physical and psychosocial  HRQOL 
 
Classical test theory analysis and Rasch 
analysis found the agreement between 
children and parents in physical domain 
was better than psychosocial domains. 
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Mah et al., 2008 Cross-sectional 
Neuromuscular sample 
N=109, 24 are DMD or 
Becker MD, mean age 10.5 
 
Single Neuromusclar centre 
in Canada 
PedsQL 4.0 General Core 
 
Parent-report 
Children who required ventilation had 
significantly lower overall HRQOL than 
children not on ventilation 
McDonald et al., 2010 Cross-sectional; 
DMD sample N=52 
ambulatory boys (age range 
4-17) 
Control sample N=36 
 
Neuromuscular clinics in the 
United States 
PedsQL 4.0 Generic Core 
Module 
 
PODCI 
 
Parent-report 
Parent reported HRQOL in both 
questionnaires are lower than those of 
controls 
 
The physical function domain of PedsQL 
and of PODCI correlated with age and 
some clinical measures of strength 
Opstal et al., 2013 Cross-sectional; 
DMD sample 
N= 40, mean age 11.5 years 
(range 8-20);  
Control group N=22,827 
 
Recruited from Dutch 
Duchenne Parent Database 
KIDSCREEN-52  
 
Self-report and parent-
report 
Apart from physical domain, HRQOL in 
Boys with DMD not significantly different 
from that of healthy boys. 
 
Significant correlations between physical 
domain and some functional scales 
Orcesi et al., 2014 Cross-sectional; 
DMD sample N=43 (out of 
78 neuromuscular patients)   
Mean age 8.6  years  (range 
5-13) 
 
Six tertiary centres in Italy  
Newly developed Strips Of 
Life with Emoticons (SOLE) 
questionnaire 
 
Self- and parent- report 
DMD patients reported lower QOL than 
healthy controls 
 
No significant correlation found between 
functional disability and SOLE total score 
 
(Simon et al., 2011) 
Longitudinal 
DMD sample N=95 (age 
range 5 to 17)   
Single neuromuscular centre 
in Brazil 
Life Satisfaction Index for 
Adolescents  
 
Self-report 
Boys with DMD showed increase in self-
perceived QOL in most domains of the 
Life Satisfaction Index over the nine 
month period of the study 
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Uzark et al., 2012 Cross-sectional; 
DMD sample N=203 mean 
age 10.4 years (age range 5-
17) 
 
Neuromuscular clinics in the 
United States (Michigan) 
PedsQL 4.0 Generic Core 
and DMD module 
 
Self- and parent-report 
Parent and child reported total and 
subdomain scores were significantly 
lower than those of healthy children. 
 
Older boys self-reported psychosocial 
score was significantly higher than that 
of younger boys. 
 
The PedsQL DMD module is reliable and 
valid 
Vuillerot et al., 2010 Cross-sectional; 
Neuromuscular sample 
N=43, 19 are DMD 
Mean age 13.8 years (range 
10-17) 
 
Single neuromuscular centre 
in France 
Vecu Sante Percu par 
L’adolescent (self-perceived 
health states in adolescents) 
Self-report 
Teens with a neuromuscular disorder did 
not report lower score than nondisabled 
group 
 
QOL scores did not correlate with 
physical impairment 
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Chapter 3  
                                 Methods 3
This chapter describes the process of data collection, data management strategies and 
statistical analyses related to each objective. The properties of the measures and variables 
used in the study are also reviewed.  
3.1 Data Source, Study Design and Data Management 
3.1.1 Data source 
Participants were recruited through the Canadian Neuromuscular Disease Registry 
(CNDR), a national registry that collects demographic and medical information from 
people living with a neuromuscular disease, including DMD, across Canada.  
The CNDR was implemented with the objective of fostering collaborative research and 
facilitating planning of clinical trials. Recruitment at the two lead sites, Calgary and 
London, began in June 2011. The National Office for the CNDR is based at the 
University of Calgary in Alberta, Canada. Nine paediatric neuromuscular clinics across 
Canada are currently enrolling patients with DMD into the registry. Patients are 
approached for enrollment during routine clinic visits. Upon enrollment, patients indicate 
whether they want to be contacted for research studies in the future.  As part of the 
registry, demographic and medical information are collected at the initial recruitment 
visit and then all follow-up visits. At each clinic visit, the treatment team completes the 
CNDR data collection forms, which are then uploaded onto a secure web-portal. All 
personnel who complete data entrance at each site are trained by the CNDR national 
coordinator. As well, there is a detailed data reference manual which outlines the 
requirement for individual fields. Data entry is reviewed on a weekly basis by the 
National Office and any errors detected are reported back to the local sites for correction. 
Finally, data are audited on a regular basis by the National Office (Korngut et al., 2013).  
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3.1.2 Data collection 
Ethics approval was obtained from the Research Ethics Board at Western University and 
the CNDR. A copy of the approval notice can be found in Appendix A. The CNDR 
national office coordinated the mail-out to all eligible families who indicated they were 
interested in participating in research. Due to the confidentiality protocol for the CNDR, 
only the national office has access to the addresses and identifying information of these 
families. A set of unique IDs was generated for this study, and only the CNDR national 
office has the list matching IDs to CNDR data.  
Inclusion criteria: 
1. Enrollment in CNDR and patient (or parent) has indicated interest to be contacted for 
research studies 
2. Males between ages of 4-18 years of age;  
3. A confirmed diagnosis of DMD in the CNDR database. The definition is confirmed 
by genetic testing or absence of dystrophin on muscle biopsy, and a phenotype 
consistent with DMD as judged by the treating physician;  
4. Availability of primary care giver to complete the parent questionnaire. 
Exclusion criteria: 
1. Any significant co-morbid medical diagnosis not related to DMD;  
2. Inability to comply with study protocol (e.g. lack of language skills to complete 
questionnaire) 
Questionnaires were compiled in London and forwarded to the national office for mail-
out in June 2013. There were two separate questionnaire booklets, one for the child to 
complete as self-report, one for the parent to complete as proxy-report. Parents and 
children were instructed to complete the questionnaires independently. In the case where 
the child was unable to complete the questionnaire on his own, parents were instructed to 
read the questions to their child verbatim and not guide the child in answering the 
question. Included with the questionnaires were a letter of information for parents and 
assent letter for children, describing the study (Appendix B). Implied consent was 
assumed for this study if the participant returned the questionnaires. One week after the 
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initial mail-out, a reminder postcard was sent out to all families. Four weeks later, a 
reminder package, containing the same elements as the initial package was sent to those 
who had not responded. Eight weeks after the initial mail-out, another reminder package 
was sent to those who had not yet responded. A copy of the reminder postcard and the 
letter accompanying the reminder package can be found in Appendix C. This method, 
consistent with the Dillman’s Tailored Design method was used to maximize the 
response rate (Dillman, 1978).  
3.1.3 Data management 
Questionnaires were initially returned to the national CNDR office at the University of 
Calgary, Canada where the respondents were cross-referenced against the master list to 
keep track of who had responded. Returned questionnaires were forwarded from Calgary 
to London. All data entry was completed at London Health Sciences Centre, Victoria 
Hospital. Data were entered into Statistical Package for the Social Sciences (SPSS) 
Statistics 21. Data verification was done by another research assistant, where 10% of the 
questionnaires were verified. The error rate was less than one percent, and errors were 
corrected by checking against the original questionnaire.  
3.2 Measures 
The boys with DMD and their parents completed questionnaires that assessed the child’s 
QOL and HRQOL. The boys and their parents also completed a questionnaire that 
assessed the child’s fatigue.  Parents answered additional questions on child 
characteristics and family information which included demographic information and the 
Family Inventory of Life Events (FILE) checklist. Instructions were provided at the front 
of the child and parent questionnaires to aid completion, these instructions can be found 
in appendices E to G. Parent report version of the various QOL and HRQOL measures, 
the fatigue measure, the demographic information measure and the FILE can be found in 
appendices H to N. All measures used are described below. 
Apart from child and parent completed information, demographic and medical 
information recorded in the CNDR database were also obtained, they are described in 
more detail later in the chapter.  
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3.2.1 QOL and HRQOL measures 
Four different measures were used to measure QOL and HRQOL. The Quality of My 
Life (QoML) Questionnaire measured both QOL and HRQOL with single-item 
statements. Three Pediatric Quality of Life Inventory (PedsQL) questionnaires were used 
as multidimensional measures of HRQOL with various degrees of disease specificity. A 
visual schematic representation of the QOL and HRQOL measures can be found in 
Figure 3.1, a summary of all measures used can be found in Table 3.1. 
Quality of My Life Questionnaire 
The Quality of My Life (QoML) Questionnaire was initially developed to measure 
overall QOL and  HRQOL as distinct constructs in children with rheumatoid arthritis 
(Feldman et al., 2000). The questionnaire consists of two single-item statements 
measured on visual analog scales (VAS). The first item states ‘overall, my life is…’ and 
the second states ‘Considering my health, my life is….’. Answers are marked along a 
100mm line for each question, with 0 being ‘the worst’ and 100 being ‘the best’. Child 
respondents assess their own QOL and HRQOL while parent respondent assess their 
child’s QOL and HRQOL. For this study, an item was removed from the original QoML, 
which was a question that assesses temporal change in QOL which asks the respondents 
to indicate ‘since the last time I was here my life is…’ better or worse, on a 5-point likert 
scale. This item was removed from this study because the questionnaires were done in a 
cross-sectional manner and there was no basis for a temporal comparison. Convergent 
validity of the QoML has been established in the paediatric rheumatology population 
(Feldman et al., 2000; Gong et al., 2007). The QoML has also been used in other 
populations, such as children with neurological impairment and children with hemophilia 
(Mahant et al., 2009; Revel-Vilk et al., 2004).  A copy of the QoML can be found in 
Appendix H. 
Pediatric Quality of Life Inventory generic core module and disease 
specific modules 
The PedsQL Inventory is a repertoire of generic and disease-specific modules that 
measure HRQOL in children and adolescents. All modules in the PedsQL inventory 
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contain multiple items which are grouped into domains. Each item asks the extent to 
which an event has been a problem for the child in the past month. For example, a 
question in the physical domain of the PedsQL 4.0 Generic Core asks ‘In the past month, 
how much of a problem have you had with participating in sports activity or exercise’. 
Each item is measured on a five-point likert scale that ranges from 0-4 (0=never, 
1=almost never, 2=sometimes, 3=often, 4=almost always). All items are reverse scored 
and linearly transformed into scale out of 100 (0=100, 1=75, 2=50, 3=25, 4=0) such that 
higher score indicates better HRQOL. 
The PedsQL Inventory modules are composed of parallel child-self report and parent-
proxy reports, and are divided into three age groups: young child (5-7 years old); child 
(8-12 years old) and teen (13-18 years old). It should be noted that in our study we 
administered the young child report to children aged 4 years old (n=6), to increase our 
sample size, particularly in the number of children who were recently diagnosed. The 
content of the items is identical, differing in language modified to be developmentally 
appropriate. For young children’s self-report, the 5-point likert scale is reduced to 3-point 
likert scale, (0=never, 2=sometimes, 4=almost always). Due to the young age of these 
children, parents were asked to act as interviewers to their child and given specific 
instructions (Appendix E).  Domain scores are computed as a sum of items divided by 
number of items answered. If more than half of items on a particular domain are missing, 
the domain score is not calculated. An overall score is calculated as the sum of items 
divided by total number of items. 
Generic Core Module 
The PedsQL 4.0 Generic Core module is a generic measure of HRQOL, it has been 
widely used in healthy children and children with various disorders (Varni et al., 2001; 
Varni et al., 2003, 2007b). It has been found to be valid and reliable specifically in the 
paediatric DMD population (Davis et al., 2010).  It consists of 23 items, grouped into 
four domains: eight questions in physical domain, and five questions in each of 
emotional, psychological and school domains.  
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In addition to domain scores and the overall score, two summary scores are also 
calculated. The physical domain score is also the physical summary score, and the 
emotional, social and school domains make up the psychosocial summary score. The 
parent proxy-report version of PedsQL 4.0 Generic Core module can be found in 
Appendix I. 
Neuromuscular module 
The PedsQL 3.0  Neuromuscular module was developed in particular to measure 
HRQOL in children with neuromuscular disorders, including those with DMD (Davis et 
al., 2010).  There are 25 items grouped into three domains: About my/my child’s 
neuromuscular disease (17 items), Communication (3 items) and About Our Family 
Resources (5 items). Each domain generates a score and there is also an overall score. 
The young child self-report version does not contain the Communication and About Our 
Family Resources domains. The Neuromuscular module has been tested primarily in a 
group of children with spinal muscular atrophy (SMA), which is another type of 
paediatric neuromuscular illness (Iannaccone et al., 2009), as well as a group of 44 boys 
with DMD and been found to be feasible, reliable and valid (Davis et al., 2010). The 
parent proxy-report version of PedsQL 3.0 Neuromuscular module can be found in 
Appendix J. 
DMD module 
The PedsQL DMD module was developed as a more DMD-specific measure of HRQOL 
(Uzark et al., 2012). It consists of 18 items, grouped into four domains: Daily Activities 
(5 items), Treatment (4 items), Worry (6 items) and Communications (3 items). There is 
no DMD module for young child self-report. It was developed simultaneously with the 
Neuromuscular module, and has been found to be feasible, reliable and valid (Uzark et 
al., 2012). The scoring instruction for this module precludes calculation of a total score, 
however, upon contacting the module developers, it was deemed appropriate to calculate 
a total score. The parent proxy-report version of PedsQL DMD module can be found in 
Appendix K. 
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Missing data 
The percent missing for each question in the child-reported PedsQL questionnaires 
ranged from 2.3% to 8.2%, with most questions having 2-3% missing values. The 
questions that had a higher missing percentage were deemed ‘not applicable’ by some 
children. For example, the question ‘how much of a problem have you had with running’ 
was deemed as not applicable by some children who had lost ambulation, some left it 
blank and wrote ‘not applicable’ next to the question. Computation of PedsQL domain 
scores only requires at least half of the questions in a given domain to be non-missing; 
percent missing of domains scores ranged from only 2.3% to 3.5%. In the parent reported 
PedsQL questionnaires, the percent missing for each question ranged from 0 to 4.1%. The 
percent missing for domain scores range from 0 to 2.1%. 
Initially, it was found that around 30% (N=25) of boys with DMD and their parents did 
not complete the Quality of My Life questionnaire. This single-page questionnaire was 
sent out again, with more detailed instructions, to those who did not complete it initially. 
A copy of the letter accompanying the additional mail-out can be found in Appendix D. 
Nine child self-reported QoML and fifteen parent-reported QoML were returned after 
mailing of single-page QoML questionnaire. Items missing in the demographic portion of 
the questionnaire were filled if such information could be found elsewhere (e.g. child’s 
date of birth can be obtained from the CNDR). Missing data on the PedsQL were handled 
according to guidelines of the questionnaire developers. 
3.2.2 Child characteristics and family information 
Child characteristics 
In addition to the QOL and HRQOL questionnaires, boys with DMD and their parents 
also assessed the child’s level of fatigue, which was measured via the PedsQL 3.0 
Multidimensional Fatigue module. It has three domains, with six items in each: General 
Fatigue, Sleep/Rest Fatigue and Cognitive Fatigue. It has been validated in paediatric 
cancer (Varni et al., 2002) and rheumatology (Varni et al., 2004) populations, among 
other diseases.  It was scored the same as the PedsQL HRQOL modules, where 
respondents indicated how much of a problem the boy with DMD had with a fatigue-
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related event. The scores were then reverse coded so that higher scores indicate less 
fatigue. A copy of the parent reported PedsQL 3.0 Multidimensional Fatigue module can 
be found in Appendix L. 
The remainder of the child characteristics questions were adapted from the Health 
Related Quality of Life in Children with Epilepsy Study (Speechley et al., 2012), with 
permission of the Principal Investigator. Parents were asked to indicate whether their 
child has a comorbid condition (asthma, cystic fibrosis, diabetes, cerebral palsy, epilepsy 
or cancer); a developmental or mental condition (developmental delay, a learning 
disability, Attention Deficit Disorder or Attention Deficit Hyperactive Disorder, Autism, 
pervasive development disorder or Asperger’s syndrome, oppositional defiant disorder, 
conduct disorder, depression and anxiety); whether child has needed and received extra 
help with school work (special education, speech language therapy, occupational therapy, 
medication or therapy for behaviour problems and medication or therapy for emotional 
problems). Parents were also asked to give their child’s month and year of birth. A few 
questions that were DMD specific were added to this questionnaire: Is your child 
currently involved in any clinical trials or other research studies for his DMD? Was your 
child diagnosed with DMD less than one year ago? Is your child able to walk (If no, did 
your child stop walking less than one year ago or greater than one year ago?)  
Family characteristics 
The child’s family’s characteristics were collected through parent questionnaires and 
included socio-demographic information including parents’ current marital status, current 
employment status, highest level of education completed, household income and other 
household members who currently reside with the child with DMD. Household income 
was divided into 13 categories: less than $5000, $5,000-$9,999; $10,000-$14,999; 
$15,000-$19,999: $20,000-$24,999; $25,000-$34,999; $35,000-$49,999; $50,000-
$74,999; $75,000-$99,999; $100,000-$149,999; $150,000-$200,000, over $200, 000, and 
‘don’t know’. Parents also completed the Family Inventory of Life Events (FILE), which 
was a 71 item of list of potential stressful events that a family may have faced. Each item 
is answered with either ‘yes’ or ‘no’ to indicate whether that particular event has occurred 
in the past year (McCubbin, 1996). Each item has a corresponding value if it is answered 
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with ‘yes’, with higher scores assigned to events causing more stress (e.g. 99=death of 
child). If an item was answered with ‘no’, it received a score of zero. The total score was 
calculated as a sum of all items. The child characteristics and family characteristics 
questionnaire can be found in Appendix M, and the FILE can be found in Appendix N. 
3.2.3 Registry information 
Medical information obtained from CNDR database included: forced vital capacity 
(FVC), left ventricular ejection fraction (LVEF), ambulation status (yes or no), 
wheelchair use status (never, intermittent, full-time), scoliosis status (yes or no), steroid 
treatment (never, past use, current use), non-invasive ventilation (yes or no), invasive 
ventilation (yes or no), cardiac medication (yes or no), type of genetic mutation, and date 
of genetic test. The child’s date of birth was also obtained to confirm date of birth 
reported by parents. In cases of discrepancy, the date of birth in registry was used. 
3.3 Statistical Analyses 
For all statistical analyses SAS software version 9.3 was used. A two-sided p-value <0.05 
was considered to be statistically significant unless otherwise stated. 
3.3.1 Description of sample characteristics 
Univariate analyses were used to examine characteristics of the sample (mean and 
standard deviation for continuous variables, frequencies and percentages for categorical 
variables).  Bivariate analyses (t- and χ2- tests) were used to determine whether non-
respondents were different from respondents on clinical characteristics obtained from the 
CNDR database. 
3.3.2 Describe the QOL and HRQOL in boys with DMD in Canada 
from both children’s and parents’ perspectives (Objective 1).  
The medians, means and standard deviations of child self-reported and parent proxy-
reported QOL and HRQOL scores of boys with DMD were calculated. As references, 
scores of healthy children (Varni et al., 2003) and scores of a sample of children with 
SMA, obtained from literature, were also reported.   
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3.3.3 Examine the relationship between QOL and HRQOL 
(Objective 2). 
The relationship between the single-item measures of QOL and HRQOL were examined 
with simple linear regression. To ensure that any relationship found between single-item 
QOL and single-item HRQOL is not due to similarity in design between these two 
measures (i.e. due to common method variance), the association between QOL and a 
multidimensional measure of HRQOL (PedsQL Generic Core total score) was examined 
with Spearman correlation. The association between the single-item measure of HRQOL 
and multidimensional measure of HRQOL was also examined with Spearman correlation. 
3.3.4 Explore child and family characteristics that contribute to any 
difference between QOL and HRQOL (Objective 3). 
Logistic regression was used to assess whether any child clinical or family characteristics 
distinguished those who rated QOL to be higher than HRQOL from those who did not. 
We decided to approach this objective by dividing our sample into two groups: boys and 
parents who rated QOL to be ‘much’ higher than HRQOL, and children and parents who 
did not rate QOL to be ‘much’ higher than HRQOL. QOL was considered much higher 
than HRQOL if the difference between them was in the top 25% of the sample. There 
was no guidance from literature on what constitutes a meaningful difference between 
QOL and HRQOL, thus we made the arbitrary decision, based on the distribution of the 
values in our sample, to dichotomize our outcome in this manner. The characteristics 
tested in the multivariable logistic regression are presented in Table 3.1, they were: age of 
child, fatigue level, ambulation status, presence of at least one mental or developmental 
disorder, total household income, parental education, and family inventory of life events 
score. Fatigue score and FILE score were presented in intervals of 10 and 50, 
respectively, to reflect more meaningful levels of change. 
3.3.5 Explore associations of child and family characteristics with 
multidimensional measures of HRQOL (Objective 4) 
To model the relationships of child and family characteristics with HRQOL, 
multivariable linear regression with backwards elimination was used. Our study was 
exploratory in nature, given that there was limited past literature on which to base our 
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selection of variables. As such, various measures of disease severity and other important 
clinical variables were selected for modeling based on clinical expertise. However, no 
factors were considered to be primary predictors of interest. Because of the nascent 
nature of our multivariable analysis, statistical regression (i.e. backwards elimination) 
was deemed as the appropriate regression method (Tabachnick & Fidell, 2013). Child and 
family characteristics were first examined individually via simple linear regressions. 
Those that were significant at the p<0.30 level entered the maximum model.  After 
backwards elimination, only the variables that contributed significantly to the regression 
(p<0.10) were kept in the final model. The entrance and retaining criteria for p-values 
were decided upon after consulting literature and examining the data (Maldonado & 
Greenland, 1993; Mickey & Greenland, 1989). 
The variables that were tested were: age of child, wheelchair status, scoliosis status, 
steroid  usage, forced vital capacity (FVC), left ventricular ejection fraction (LVEF), 
having at least one developmental or mental disorder,  self- or parent-perceived fatigue 
level (measured by PedsQL 3.0 Multidimensional Fatigue scale), family inventory of life 
events (FILE) score, annual household income and parent’s highest level of education. 
Clinical factors, such as wheelchair status and FVC, were chosen based on clinical 
experience and existing literature (McDonald et al., 2010). Demographic factors, namely, 
parental education and annual household income were included in the regression model 
as they had been shown to be associated with children’s HRQOL (Rueden et al., 2006). 
The FILE measure had also been shown to be a significant predictor of HRQOL in 
chronically  children, thus it was included as a potential determinant of HRQOL 
(Speechley et al., 2012).  Similarly, fatigue was associated with HRQOL in the pediatric 
cancer population (Meeske et al., 2004) and thus examined in our sample.  A separate set 
of analyses was carried out to determine the effect of FVC. Data on FVC were available 
for 67 children, and as SAS uses list-wise deletion, the sample size for the regression 
analyses would have been reduced to 67. Thus, one set of analyses was done with all 
variables in the model except for FVC to test for joint effect of these variables, then a 
separate set of analyses was carried out to assess the effect of FVC in the 67 children 
with a FVC value. LVEF was another variable that was influenced by list-wise deletion, 
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however, it did not meet the entrance criteria to enter into the maximum model, and thus 
was not relevant to the final models. The variables are presented in Table 3.3.  
3.3.6 Compare QOL and HRQOL of ambulant boys who were 
diagnosed recently to those who were diagnosed longer ago             
(Objective 5). 
QOL and HRQOL scores of ambulatory children who were diagnosed after 2012 were 
compared to ambulatory children who were diagnosed before 2012 using Kruskal Wallis 
tests. 
3.3.7 Compare QOL and HRQOL of boys who lost ambulation 
recently to those who lost ambulation longer ago    
(Objective 6). 
QOL and HRQOL scores of children who lost ambulation after 2012 were compared to 
those who have lost ambulation before 2012 with Kruskal Wallis test. 
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QOL 
HRQOL 
Single-item measure Multidimensional measures 
Specificity of HRQOL measure 
Figure 3-1 Schematic representation of measures of QOL and HRQOL 
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Table 3-1 Summary of child- and parent-reported QOL and HRQOL measures 
 Content of questionnaire QOL or 
HRQOL 
measure 
Single-item or 
Multidimensional 
Generic or 
disease specific 
measure 
Scoring 
Quality of My Life  “overall, my life is…”  QOL 
 
Single-item  
Generic 
100 mm VAS 
between ‘the worst’ 
and ‘the best’ 
 
“Considering my health, my 
life is…” 
 
HRQOL Single-item 
PedsQL 4.0 Generic 
Core 
Physical 
Emotional, Social and 
School 
(make up the psychosocial 
summary score) 
 
23 items in total 
HRQOL Multidimensional Generic How much a problem 
has…been in the past 
month, on a scale of 
0-4. Items are reverse 
transformed to score 
out of 100, higer 
score indicates higher 
HRQOL 
PedsQL 3.0 
Neurmuscular 
module 
About My/my child’s 
neuromuscular disease ; 
Communication ; About our 
family resources 
 
25 items in total 
 
HRQOL Multidimensional Disease specific Same as above 
PedsQL Duchenne 
Muscular 
Dystrophy module 
Daily activities ; Treatment 
Barrier ; Worry; 
Communication 
 
18 items in total 
HRQOL Multidimensional Disease specific Same as above 
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Table 3-2 Child and family factors tested in multivariable logistic regressions of 
child or parent rating QOL to be much higher than HRQOL 
Clinical factors Demographic factors 
- Age 
- Fatigue level 
- Presence of at least one mental or 
developmental disorder (Yes/No) 
- Parental education (no post-secondary 
education; post-secondary education) 
- Annual household income* 
- Family Inventory of Life Events score  
For categorical variables, the reference category is in bold and italicized  
*Annual household income was treated as a continuous variable as it had 13 levels 
 
 
 
 
Table 3-3 Child and family factors tested in multivariable regressions with 
multidimensional HRQOL as outcomes 
For categorical variables, the reference category is in bold and italicized 
*Annual household income was treated as a continuous variable as it had 13 levels 
 
Clinical factors Demographic factors 
- Age 
- Fatigue level 
- Forced vital capacity 
- Left ventricular ejection volume 
- Use of steroid (Yes/No) 
- Scoliosis (Yes/No) 
- Presence of at least one mental or 
developmental disorder (Yes/No) 
- Wheelchair status (Never used, 
intermittent use, permanent use) 
- Parental education (high school or less; 
vocational training; post-secondary 
education) 
- Annual household income* 
- Family Inventory of Life Events score 
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Chapter 4  
                                   Results 4
This chapter presents results of the study corresponding to each objective. The initial 
section describes the sample characteristics.  
4.1 Sample Characteristics 
From the Canadian Neuromuscular Disease Registry (CNDR), 176 eligible families were 
identified. One child was excluded because his parent identified him as having epilepsy, a 
significant co-morbidity, reducing the total number eligible to 175. Of these, 98 families 
returned completed questionnaires, for a response rate of 56%. Eight families were lost to 
follow-up due to incorrect addresses. Both parent and child completed questionnaires in 
84 families, 13 families completed the parent questionnaire only and one family returned 
the child questionnaire only.  
The children’s clinical and demographic characteristics of are presented in Table 4.1. The 
average age of the children [mean (SD)] was 10.5 (3.6) years. The majority (72%) of 
children are ambulant. Over half had at least one mental or developmental disorder, with 
developmental delay being the most common (23%).  
Characteristics of the family are presented in Table 4.2. The majority of parents who 
completed the questionnaire were mothers, and the mean age of the parent respondent 
was 43 years. Over half of parent respondents who completed the questionnaire had post-
secondary education, and the median household income was in the range of $75,000-
$99,000, which is around the national average (Government of Canada, 2013).  
Non-respondents 
Aggregate clinical characteristics of boys who did not respond were obtained from the 
CNDR and are compared to those of respondents Table 4.1. Clinical characteristics of 
non-respondents were not statistically significantly different from the respondents based 
on these comparisons. However, the boys not in the study sample were older by one year, 
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on average, and were slightly more likely to have lost ambulation, suggesting they may 
be at a more severe stage of the disease. 
4.2 Describe the QOL and HRQOL of boys with DMD in 
Canada from both child and parent perspectives 
(Objective 1).  
Child self-report 
On the QoML, the median QOL score, as reported by the boys, was 80.0, with a range of 
37.8-100, the median HRQOL score was 77, and ranged from 0 to 100. As a reference, 
the median QOL and HRQOL scores reported by children with rheumatoid arthritis were 
93 and 89, respectively. 
The child self-reported PedsQL 4.0 Generic Core, the PedsQL 3.0 Neuromuscular 
Module and the PedsQL DMD Module mean scores, standard deviations and ranges are 
presented in Table 4.3. As a reference, scores of healthy children and those with another 
neuromuscular disorder, spinal muscular atrophy (SMA), which were obtained from 
literature (Iannaccone et al., 2009; Varni et al., 2001), are also presented. Compared to 
the healthy sample, the score of boys with DMD are lower in all domains of the PedsQL 
4.0 Generic Core module, with largest difference in the physical domain, and the smallest 
in the emotional domain. The PedsQL 4.0 Generic Core total and domain scores 
comparing boys with DMD and children with SMA were very similar to one another. On 
the PedsQL 3.0 Neuromuscular module, boys with DMD had higher mean score in 
“About my neuromuscular disease’ domain, but a lower mean score in ‘Communication’ 
domain than children with SMA.      
Parent proxy-report 
On the QoML, the median QOL score of boys with DMD, as reported by their parents, 
was 72, the scores ranged from 8 to 100. The median HRQOL score was 67, and ranged 
from 16 to 100. As a reference, the median QOL and HRQOL scores reported by parents 
of children with rheumatoid arthritis were 90 and 91, respectively (Gong et al., 2007).  
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The parent proxy-reported PedsQL 4.0 Generic Core, the PedsQL 3.0 Neuromuscular 
Module and the PedsQL DMD module mean scores, standard deviations and ranges are 
reported in Table 4.4. As a reference, normative scores of healthy children and those with 
spinal muscular atrophy, which were obtained from literature (Iannaccone et al., 2009; 
Varni et al., 2001), were also presented. Compared to the healthy sample, the parent-
reported score of boys with DMD are lower in all domains of the PedsQL 4.0 Generic 
Core module, the difference was largest in the physical domain, and smallest in the 
emotional domain. Parents of boys with DMD rated their sons to have better physical 
HRQOL, but worse psychosocial HRQOL than parents of children with SMA. On the 
PedsQL 3.0 Neuromuscular module, parents of boys with DMD rated their sons to have 
higher score in ‘About my neuromuscular disease’ and ‘About our family resources’ 
domains, but lower score in ‘Communication’ domain than parents of children with 
SMA.      
4.3 Examine the relationship between QOL and HRQOL 
(Objective 2). 
The relationship between single-item measures of QOL and HRQOL on the QoML were 
examined with simple linear regression. On the child self-report, two boys rated their 
QOL as 100 mm, and HRQOL as 0 mm. These extreme values were deemed as outliers 
and removed from analysis. Better HRQOL was associated with better QOL 
(QOL=0.45*HRQOL+44.25, p<0.0001). The adjusted R
2
 was 0.21. The single-item QOL 
score did not correlate significantly with the multidimensional PedsQL 4.0 Generic Core 
total score (r=0.17, p=0.17). The single-item HRQOL score was significantly correlated 
with the PedsQL 4.0 Generic Core total score (r=0.30, p=0.01).  
On the parent reported QoML, better HRQOL was associated with better QOL 
(QOL=0.58*HRQOL+31.00, p<0.0001). The adjusted R2 was 0.44. The single-item 
QOL score did not correlate with multidimensional PedsQL 4.0 Generic Core total score 
(r=0.14, p=0.21). The single-item HRQOL score significantly correlated with the PedsQL 
4.0 Generic Core total score (r=0.25, p=0.03). 
46 
 
4.4 Explore child and family characteristics that contribute 
to any difference between QOL and HRQOL (Objective 
3). 
Multivariable logistic regressions were run to investigate what child and family 
characteristics contributed to child and parent respondents rating QOL to be higher than 
HRQOL. QOL was deemed to be higher than HRQOL if the difference between QOL 
and HRQOL was in the top 25% of the sample. The factors that entered the logistic 
regressions were: age of child, ambulation status, fatigue level, parent’s highest level of 
education, total household income and FILE score. 
Child self-report 
The difference between QOL and HRQOL ranged from 100mm to -46.3mm, the median 
difference was 0.8mm. QOL was deemed to be higher than HRQOL if it was 14.9 mm or 
greater than HRQOL. None of the child or family characteristics tested was significantly 
associated with a child respondent rating his QOL to be higher than HRQOL (Table 4.5). 
However, children whose parents have post-secondary education were 5.7 times more 
likely to rate their QOL to be much higher than HRQOL, with a very wide confidence 
interval (CI: 0.7-237), due to the small sample size. 
Parent proxy-report  
The median difference between QOL and HRQOL was 0, and ranged from 55mm to -
42.5mm. QOL was considered to be higher than HRQOL if it was 9.6mm or higher than 
HRQOL. None the factors was significantly associated with an increased likelihood of a 
parent rating their child’s QOL to be higher than HRQOL (Table 4.6). However, the lack 
of significance could be due to the small sample size. For example, the odds ratio of 
rating QOL to be higher is 4.5, comparing parents of ambulant boys to parents of non-
ambulant boys, the confidence interval is from 0.9 to 35.9. As with the child report one 
factor associated with QOL being higher than HRQOL was parent education level, 
parents who have post-secondary education were 2.0 times more likely to rate their son’s 
QOL to be higher than HRQOL (CI: 0.6-7.4). 
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4.5 Explore the association of clinical and demographic 
characteristics with multidimensional measures of 
HRQOL (Objective 4) 
Regression analyses were carried out on the following HRQOL outcomes in child self 
and parent proxy-reports: PedsQL 4.0 Generic Core total score, physical summary score, 
psychosocial summary score, PedsQL 3.0 Neuromuscular Module total score and 
PedsQL DMD Module total score. Bivariate regression analyses were conducted on each 
of the explanatory variables and the HRQOL outcomes, and variables that had p-values 
of less than 0.3 entered the maximum main effects models. The model selected was 
backwards elimination, variables that had p-values of less than 0.1 stayed in the final 
model. Two sets of analyses were run, one with FVC in the model, one without.  
The child and family characteristics that remained in the final model had p-value less 
than 0.10. The results of the regression models without and with FVC are presented 
below (parameter estimate (SE)). The results of models without FVC are presented in 
Tables 4.7 and 4.8. The assumptions of linear regression were met and the test for 
collinearity was not significant. Results for each of the HRQOL outcomes in child self-
report are presented first, followed by parent proxy-report. 
Child report 
PedsQL 4.0 Generic Core Total Score 
The factors that were significantly associated with the PedsQL 4.0 Generic Core total 
score were fatigue, intermittent use and full-time use of wheelchair and parent’s highest 
level of education. The R
2
 was 0.61. Children who reported less fatigue reported better 
HRQOL (0.57(0.06)). Compared to children who did not use wheelchair, children who 
used wheelchair intermittently (-7.47(2.36)) and who used a wheelchair full-time            
(-15.14(2.46)) had significantly worse overall HRQOL. Compared to children whose 
parent’s highest level of education was high school or less, children who have a parent 
with college or university education had significantly better overall HRQOL (4.34(2.07)). 
With FVC added to the model, the factors that remained significant in the final model 
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were: fatigue (0.62(0.08)), intermittent wheelchair use (-8.53(3.03)) and full-time 
wheelchair use (-13.11(3.00)). The R
2
 for this model was 0.64.  
PedsQL Generic Core 4.0 Physical Summary Score  
The factors that remained in the final model of the physical summary score were fatigue, 
intermittent and full-time use of wheelchair. The R
2
 was 0.72. The children who reported 
less fatigue had significantly higher physical summary score (0.46(0.09)). Children who 
used wheelchair intermittently (-19.92(3.40)) and full-time (-42.41(3.48)) reported 
significantly lower physical summary scores than children who did not use a wheelchair. 
With FVC added to the model, the factors that remained significant in the final model 
were: fatigue (0.47(0.12)), intermittent wheelchair use (-19.86(4.36)) and full-time 
wheelchair use (-39.35(4.38)). The R
2
 for this model was 0.67.  
PedsQL Generic Core 4.0 Psychosocial Summary score   
The factors that were significantly associated with the Psychosocial Function score were 
fatigue and annual household income. The R
2
 was 0.56.  Less fatigue (0.68(0.07)) and 
higher household income (1.14(0.46)) were associated with better psychosocial HRQOL. 
FVC did not meet the criteria to enter the maximum model.  
PedsQL Neuromuscular Module 3.0 Total Score  
The factors that remained in the final model for the Neuromuscular module total score 
were: age, fatigue, household income and full-time use of wheelchair. The R
2 
was 0.76. 
Older children (0.57(0.27)), those with less fatigue (0.74(0.05)) and higher household 
income (0.55(0.31)) reported better HRQOL on the Neuromuscular module. Compared to 
boys who did not use wheelchairs, those who use wheelchair full-time (-12.45(2.25)) 
reported worse HRQOL. With FVC added to the model, the factors that were significant 
were fatigue (0.70(0.07)), full-time use of wheelchair (-8.91(2.26)) and total household 
income (0.80(0.42)). The R
2
 was 0.72.  
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PedsQL DMD Module Total Score  
The factors that remained in the final model of PedsQL DMD module total score were 
fatigue, FILE score, total household income and full-time use of wheelchair. The R
2
 was 
0.60. The boys who reported less fatigue 0.88((0.09)), whose family had higher FILE 
score (more stresses) (0.01(0.006)) and higher household income (0.98(0.08)) had 
significantly better HRQOL on the DMD module. Boys who use wheelchair full-time (-
14.3(2.90)) had significantly worse HRQOL than boys not in wheelchair. With FVC 
added to the model, the factors that remained in the final were fatigue (0.71(0.09)) and 
FVC (0.40(0.08)). The R
2
 was 0.65.  
Parent report 
PedsQL 4.0 Generic Core Total score 
The factors that remained in the final model were fatigue, intermittent use of wheelchair, 
full-time use of wheelchair, and parent’s highest level of education. The R2 was 0.48. 
Parents who reported their children to have less fatigue (higher score) also reported better 
HRQOL (0.53(0.08) for their children on the PedsQL Generic Core module. Compared to 
parents of children who did not use a wheelchair, parents of children who use a 
wheelchair intermittently (-9.60(2.9)) or full-time (-8.49(3.2)) reported significantly 
worse HRQOL for their children. Parents who had post-secondary education reported 
significantly higher HRQOL (6.77(2.6)) compared to parents whose highest level of 
education was high school education or less. With FVC added to the model, the factors 
that remained significant in the final model were: fatigue (0.51(0.10)), intermittent 
wheelchair use (-9.70(3.68)), full-time wheelchair use (-7.07(3.92)) and parent having 
post-secondary education (5.57(3.25)). The R
2
 for this model was 0.44.  
PedsQL Generic Core 4.0 Physical Summary Score  
The factors that remained in the final model of the physical summary score were fatigue, 
intermittent use of wheelchair, full-time use of wheelchair, and parent’s highest level of 
education. The R
2
 was 0.25. Parents who reported their children as having less fatigue 
(0.37(0.2)) also reported better physical summary score for their children. Compared to 
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parents of children who did not use a wheelchair, parents of children who used a 
wheelchair intermittently (-15.07(5.5)) or full-time (-18.90(6.0)) reported significantly 
better HRQOL for their children. Parents who had post-secondary education reported 
significantly better HRQOL for their children (11.54(4.8)) compared to parents whose 
highest level of education was high school education or less. With FVC added to the 
model, the factors that remained significant in the final model were: fatigue (0.34(0.18)), 
intermittent wheelchair use (-19.27(6.89)) and full-time wheelchair use (-19.94(7.41)). 
The R
2
 for this model was 0.18.  
PedsQL Generic Core 4.0 Psychosocial Summary Score   
The factors that remained in the final model of the psychosocial summary score were age, 
intermittent use of wheelchair, fatigue, household income, and having at least one 
developmental or mental disorder. The R
2
 was 0.53. Parents whose children were 
younger (-0.73(0.3)), who reported their children to have less fatigue (0.58(0.08)) and 
those with a higher household income (0.81(0.5)), reported better psychosocial summary 
score for their children. Compared to parents of children who do not have any 
developmental or mental disorder, parents of children who have at least one disorder 
reported significantly worse HRQOL (-4.50(2.5) for their children. Compared to parents 
of children who did not use a wheelchair, parents of children who used a wheelchair 
intermittently (-4.70(2.6)) reported significantly worse HRQOL. With FVC added to the 
model, the factors that remained in the final model were fatigue (0.58(0.08), intermittent 
use of wheelchair (-6.35(2.9)) and parent whose highest level of education is vocational 
training (9.24(4.4)) or post-secondary education (9.88(3.7)) compared to high school 
education. The R
2
 was 0.53. 
PedsQL Neuromuscular Module 3.0 Total Score  
The factors that remained in the final model of Neuromuscular 3.0 module total score 
were fatigue, full-time wheelchair use, and the FILE score. The R
2
 was 0.70. Parents who 
reported their children to have less fatigue (0.62(2.37)) and lower FILE score (less stress) 
(-0.01(0.004)) also reported better HRQOL on the neuromuscular module. Compared to 
parents of children who did not use a wheelchair, parents of children who used a 
51 
 
wheelchair full-time (-15.6(2.38)) reported significantly worse HRQOL. With FVC 
added to the model, the factors that remained in the final model were fatigue (0.72(0.07)), 
intermittent use of wheelchair (-5.88(2.9)) and full-time use of a wheelchair (-16.9(3.03)). 
The R
2
 for this model was 0.73.  
PedsQL 3.0 DMD Module Total Score  
The factors that remained in the final model of the DMD module total score were fatigue, 
full-time wheelchair use, and household income. The R
2
 was 0.66. Parents who reported 
their children to have less fatigue (0.70(0.07)) and who had higher household income 
(1.27(0.5)) reported higher DMD module score. Compared to parents of children who did 
not use a wheelchair, parents of children who used a wheelchair full-time (-15.45(2.8)) 
reported significantly worse HRQOL for their children. In the group with FVC in the 
model, the factors that remained in the final model were age (-1.19(0.5)), fatigue 
(0.78(0.08)), FVC (0.25(0.08)), intermittent wheelchair use (6.01(3.1)), and household 
income (1.09(0.60)). The R
2
 for this model was 0.74.  
Summary of regression analyses 
The factors most consistently associated with HRQOL outcomes were level of fatigue 
and wheelchair use. Fatigue level was significantly associated with every HRQOL 
outcome for both child and parent reports, and in greater magnitude than other variables. 
The use of a wheelchair was associated with all HRQOL outcomes except for child-
reported PedsQL Generic Core psychosocial score. In both parent and child reports, 
parent’s highest level of education were significantly associated with the PedsQL Generic 
Core total score. For both child and parent report, FVC remained in the final model of the 
DMD module total score. 
4.6 Compare QOL and HRQOL of ambulant boys who were 
diagnosed recently to those who were diagnosed longer 
ago (Objective 5). 
The mean age of boys diagnosed after 2012 was 5.8, of those diagnosed before 2012 was 
9.5. The mean self-reported and parent-reported scores of boys diagnosed since 2012 
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(N=5) were compared against those who were diagnosed before 2012 (N=51) but were 
still ambulant are presented in Table 4.9. Wilcoxon rank sum test was carried out, and no 
significant differences were found in any of the scores. 
4.7 Compare QOL and HRQOL of boys who lost 
ambulation recently to those who lost ambulation longer 
ago (Objective 6). 
The mean self-reported and parent-reported scores of boys who lost ambulation after 
2012 (N=3) were compared to those who lost ambulation before 2012 (N=20) are 
presented in Table 4.10. Wilcoxon rank sum test was carried out, no significant 
differences were found in any of the scores. 
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Table 4-1 Demographic and clinical characteristics of respondent and non-
respondent boys with DMD 
Variables Respondents 
N=98 
Non-respondents 
N=77 
Age (years, SD) 10.7 (3.7) 11.7 (3.2) 
Ambulant (%) 72.4 64.0 
Wheelchair use:  intermittent 
 
                               full-time 
25.5 
 
23.5 
31.0 
 
25.0 
Currently receiving steroid (%)  80.6 85.7 
Scoliosis (%): surgically corrected 
 
                 Not surgically corrected 
4.0 
 
8.1 
Not available 
Cardiomyopathy (%) 5.1 6.4 
Receive non-invasive ventilation (%) 6.1 2.1 
Last FVC mean (SD) 
(n=67) 
78.8 (17.7) 80.5 
LVEF mean (SD) 
(n=72)  
64.7 (7.2) 62.4 
Co-morbidities  
 
2* 
 
- 
Developmental or mental  disorder 
(%) 
Developmental delay 
Learning disorder 
Attention deficit disorder 
Autism spectrum disorder 
Oppositional defiant disorder 
Conduct disorder 
Depresion 
Anxiety 
Have at least one developmental or 
mental disorder 
 
 
 
22.4 
28.6 
16.3 
10.2 
2.0 
0 
5.1 
14.3 
55.1 
- 
Participation in clinical trial(%) 28.6 - 
*2 boys had asthma, they were kept in the sample as asthma could be a consequence of 
pulmonary function decline  
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Table 4-2 Characteristics of respondent families  
Variables Respondents 
N=98 
Age of parent respondent (years, SD) 42.7 (7.0) 
Biological parent (%) 91.8 
Female (%) 72.0 
Married (%) 80.6 
Living with spouse or partner 87.8 
Mean household size 3.0 
Parent’s highest level of education (%) 
    High school or less 
    Vocational 
    College/university 
    Choose not to answer 
 
18.3 
15.3 
61.2 
4.1 
Parent’s work status 
    Not working 
    Working 
    Homemaker 
 
20.4 
61.2 
16.3 
Household income (%) 
                                  <$25,000 
                       $25,000 - $50,000  
                        $50,000-$74,999 
                      $75,000 - $99, 999 
                   $100,000 –$149,999 
                    ≥$150, 000 
                  Don’t know                   
 
12.2 
18.4 
9.2 
16.3 
16.3 
19.3 
6.1 
Family Inventory of Life Events score (Mean, SD) 314.3 (260.1) 
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Table 4-3 Mean self-reported PedsQL Generic Core, Neuromuscular and DMD 
module scores in boys with DMD, children with spinal muscular atrophy and 
healthy children 
 Boys with DMD 
 
   N        Mean (SD) 
                [range] 
Spinal Muscular Atrophy 
(Iannaccone et al., 2009) 
      
    N                Mean (SD) 
Healthy 
(Varni et al., 2001) 
     
  N              Mean (SD) 
Generic Core Total 
score 
82 58.3 (15.5) 
[25.0-97.8] 
125 58.7 (14.4) 401 83.0 (14.8) 
  Physical   
summary score 
82 45.3 (23.8) 
[3.1-100] 
123 43.4 (21.1) 400 84.4 (17.3) 
  Psychosocial 
summary score 
83 65.4 (15.5) 
[31.7-96.7] 
125 66.6 (16.3) 399 82.4 (15.5) 
        Emotional 83 66.4 (21.5) 
[20.0-100] 
125 67.0 (23.0) 400 80.9 (19.6) 
        Social 83 63.3 (18.3) 
[20.0-100] 
125 66.1 (19.5) 399 87.4 (17.2) 
        School 
 
81 66.7 (19.4) 
[20.0-100] 
124 66.2 (20.9) 386 78.6 (20.5) 
Neuromuscular 
module Total 
Score 
83 72.0 (13.5) 
[37.0-97.0] 
 
123 67.5 (15.6) - - 
   About my   
Neuromuscular 
disease 
82 71.7 (13.9) 
[38.2-98.4] 
123 65.9 (16.5) - - 
   Communication 64 63.9 (26.4) 
[37.0-97.0] 
80 70.8 (23.6) - - 
   About our family 
resources 
 
64 74.9 (20.1) 
[20.0-100] 
80 74.7 (22.2) - - 
DMD Total Score 64 66.6 (17.8) 
[26.3-100] 
- - - - 
   Daily activities 64 64.6 (25.0) 
[15.0-100] 
- - - - 
   Treatment 64 72.6 (24.2) 
[6.3-100] 
- - - - 
   Worries 64 65.4 (21.9) 
[16.7-100] 
- - - - 
   Communication 64 63.1 (28.3) 
[0-100] 
- - - - 
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Table 4-4 Mean parent reported PedsQL Generic Core, Neuromuscular and DMD 
module scores in boys with DMD, children with spinal muscular atrophy and 
healthy children 
Parent report Boys with DMD 
 
N          Mean (SD) 
          [range] 
Spinal Muscular Atrophy 
(Iannaccone et al., 2009) 
 
N            Mean (SD) 
Healthy 
(Varni et al., 2001) 
 
N            Mean (SD) 
Generic Core Total 
Score 
 95 51. 9 (16.5) 
[21.7-93.5] 
174 53.4 (14.2) 717 87.6 (12.3) 
  Physical 
 summary score  
 95 42.8 (25.7) 
[0-96.9] 
172 36.3 (24.6) 717 89.3 (16.4) 
  Psychosocial 
summary score 
 95 57.2 (15.7) 
[28.3-95] 
174 74.8 (18.2) 717 86.6 (12.8) 
     Emotional domain  95 62.2 (18.0) 
[15.0-100] 
173 62.2 (17.6) 718 82.6 (17.5) 
     Social domain  95 50.0 (20.0) 
[8.3-100] 
174 57.4 (17.4) 716 91.6 (14.2) 
     School domain  95 58.7 (19.5) 
[25.0-100] 
154 63.8 (20.0) 611 85.5 (17.6) 
Neuromuscular 
Module Total Score 
96 67.3 (17.0) 
[25.0-97] 
172 59.7 (16.8) - - 
  About my 
Neuromuscular 
disease 
96 69.2 (17.3) 
[23.5-100] 
176 58.8 (17.7) - - 
  Communication 96 58.0 (28.6) 
[0-100] 
172 67.0 (31.1) - - 
  About our family   
resources 
96 66.7 (23.9) 
[26.3-100] 
176 59.6(22.2) - - 
DMD Module Total 
Score 
97 61.5 (18.8) 
[13.9-95.8] 
- - - - 
  Daily activities 97 56.3 (25.5) 
[0-100] 
- - - - 
  Treatment 96 70.8 (23.5) 
[6.3-100] 
- - - - 
  Worries 97 60.7 (24.7) 
[0-100] 
- - - - 
  Communication 93 58.9 (30.2) 
[0-100] 
- - - - 
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Table 4-5 Results of multivariable logistic regression of rating QOL to be much 
higher HRQOL on child-reported QoML (N=64). 
Parameter Odds Ratio 95% Confidence Limits 
Ambulation 0.6 0.1 - 3.2 
Household income 1.0 0.8 - 1.5 
Age 1.1 0.8 - 1.4 
Parent’s highest level  of education 
(post-secondary v.s. not) 
5.7 0.7 - 237 
Presence of at least one developmental 
Or mental disorder 
0.7 0.1- 2.9 
Fatigue score 0.7 0.4 - 1.0 
FILE score 0.9 0.7 - 1.0 
QOL was considered to be much higher than HRQOL if QOL was 14.9 mm or greater than 
HRQOL on the VAS (in the top 25%). 
Fatigue score: higher fatigue score indicates less fatigue, score was divided by 10 to reflect a 
more meaninful level of change. The odds ratio is that of child with DMD rating his QOL to be 
much higher than HRQOL for every 10 unit of increase in fatigue score.  
FILE: higher FILE score indicates higher level of family stress experienced in the past year. Score 
was divided by 50 to reflect a meaningful level of change. Odds ratio represents odds ratio of 
child with DMD rating his QOL to be much higher than HRQOL for every 50 unit of increase in 
FILE score 
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Table 4-6 Results of logistic regression for rating QOL to be much higher than 
HRQOL on parent-reported QoML (N=74). 
Parameter Odds Ratio 95% Confidence Limits 
Ambulation 5.3 0.8 - 35.9 
Household income 0.9 0.8 - 1.1 
Age 1.0 0.8 - 1.2 
Parent’s highest level  of education 
(post-secondary v.s. not) 
2.0 0.6 - 7.4 
Presence of at least one developmental 
Or mental disorder 
0.6 0.1 - 1.3 
Fatigue score 0.7 0.5 - 1.0 
FILE score 1.0 0.9 - 1.1 
QOL was considered to be much higher than HRQOL if QOL was 9.4 mm or greater than HRQOL 
on the VAS (in the top 25%). 
Fatigue score: higher fatigue score indicates less fatigue, score was divided by 10 to reflect a 
meaninful level of change. The odds ratio is that of parent who rated their child’s QOL to be much 
higher than HRQOL for every 10 unit of increase in fatigue score.  
FILE : higher score indicates higher level of family stress experienced in the past year. Score was 
divided by 50 to reflect a meaningful level of change. Odds ratio is that of parent who rated child 
with DMD’s QOL to be much higher than HRQOL for every 50 unit of increase in FILE score 
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Table 4-7 Results of backwards elimination models of child and family factors on various 
child-reported PedsQL measures. 
FVC was not included in models to maximize sample sizes 
Parameter estimate and p-value of factors that remained significant (p<0.10) in the final model after backwards 
elimination are presented 
N.S. - Not significant after backwards elimination;  
The variables scoliosis and LVEF did not meet criteria to enter maximum model for any of the HRQOL outcomes, 
they are not presented in the table. Binary variables (coded as Yes/No) are steroid and presence of at least one 
developmental or mental disorder, the reference group is “No”.  Multilevel categorical variables are wheelchair 
status and parental education, the reference category is indicated as ‘ref.’ Parameter estimates in continuous 
variables indicates amount of change in HRQOL for one unit change in the explanatory variables.
 PedsQL 4.0 
Generic 
Core Total 
(N=69) 
PedsQL 4.0 
Generic Core 
Physical 
(N=71) 
PedsQL 4.0 
Generic Core 
Psychosocial 
(N=79) 
PedsQL 3.0 
Neuromuscular 
Total 
(N=75) 
PedsQL 
DMD Total 
 
(N=59) 
Age 
 
N.S. N.S. N.S. 0.57 (0.3) N.S. 
Fatigue 
 
0.57 
(<0.0001) 
0.46 (<0.0001) 0.67 (<0.0001) 
 
0.74 (<0.0001) 0.88 
(<0.0001) 
FILE score 
 
N.S. N.S. N.S. N.S. 0.011 
(0.006) 
Household income 
 
 
N.S. 
 
N.S. 
 
1.14 (0.02) 
 
0.55 (0.06) 
 
N.S. 
Wheelchair 
    Never (ref.) 
    
    Intermittent  
           
     
    Full-time 
 
--- 
 
-7.47 
(0.002) 
 
-15.14 
(<0.0001) 
 
 
--- 
 
-19.92 
(<0.0001) 
 
-42.41 
(<0.0001) 
 
 
 
 
 
Did not enter 
maximum 
model 
 
--- 
 
N.S. 
 
 
-12.4 
(0.0004) 
 
--- 
 
N.S. 
 
 
-14.51 
(<0.0001) 
 
Steroid 
 
N.S. N.S. N.S. N.S. N.S. 
≥1 developmental 
or mental disorder 
 
 
 
N.S. 
 
 
N.S. 
 
 
N.S. 
 
Did not enter 
maximum model 
 
Did not enter 
maximum 
model 
Parental education 
    ≤ High school 
(ref.)   
   Vocational 
    
  Post-secondary 
 
 
--- 
N.S. 
 
4.34 (0.04) 
 
 
Did not enter 
maximum 
model 
 
 
Did not enter 
maximum 
model 
 
 
Did not enter 
maximum model 
 
 
Did not enter 
maximum 
model 
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Table 4-8 Results of backwards elimination models of child and family factors on various 
parent-reported PedsQL measures. 
 PedsQL 4.0 
Generic 
Core Total  
(N=85) 
PedsQL 4.0 
Generic Core 
Physical  
(N=85) 
PedsQL 4.0 
Generic Core 
Psychosocial 
(N=85) 
PedsQL 3.0 
Neuromuscular 
Total 
(N=88)  
PedsQL  
DMD Total 
 
(N=90) 
Age N.S. 
 
N.S. 
 
-0.73 (0.030) 0.62 N.S. 
 
Fatigue 
 
0.53 
(<0.0001) 
0.37 (0.02) 0.57 (<0.0001) 0.62 (<0.0001) 0.7 (<0.0001) 
FILE score 
 
N.S. 
 
N.S. 
 
N.S. 
 
Did not enter 
maximum model 
N.S. 
 
Total household 
income 
 
N.S. 
 
 
N.S. 
 
 
0.82 
 
 
N.S. 
 
 
1.27 (0.011) 
Wheelchair 
    Never (ref.) 
 
    Intermittent 
  
    Full-time 
 
 
--- 
 
-9.60 (0.0099) 
 
-8.49 (0.0101) 
 
--- 
 
-16.27 (0.007) 
 
-19.94 (0.002) 
 
 
--- 
 
-4.7 (0.08) 
 
N.S. 
 
--- 
 
N.S. 
 
-15.6 (<0.0001) 
 
--- 
 
N.S. 
 
-16.10 
(<0.0001) 
Scoliosis 
 
N.S. 
 
Did not enter 
maximum 
model 
N.S. 
 
Did not enter 
maximum model 
Did not enter 
maximum 
model 
≥1 developmental 
or mental disorder 
 
 
N.S. 
 
 
 
N.S. 
 
 
 
-4.46 (0.074) 
 
 
N.S. 
 
 
N.S. 
 
Parental 
education 
    ≤ High school   
(ref.) 
    Vocational  
     
Post-secondary  
 
 
 
--- 
N.S. 
 
6.78 (0.010) 
 
 
 
--- 
N.S. 
 
11.54 (0.02) 
 
 
 
--- 
N.S. 
 
N.S. 
 
 
 
Did not enter 
maximum model 
 
 
Did not enter 
maximum 
model 
FVC was not included in models to maximize sample sizes. 
Parameter estimate and standard error of factors that remained significant (p<0.10) in the final model after 
backwards elimination are presented. 
N.S. - Not significant after backwards elimination 
The variables steroid and LVEF did not meet criteria to enter maximum model for any of the HRQOL outcomes, 
they are not presented in the table. 
Binary variables (coded as Yes/No) are steroid, scoliosis and presence of at least one developmental or mental 
disorder, the reference group is  “No”. Multilevel categorical variables are wheelchair status and parental 
education, the reference category is indicated as ‘ref.’. Parameter estimates in continuous variables indicates 
amount of change in HRQOL for one unit change in the explainatory variabels.   
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Table 4-9 QoML and PedsQL 4.0 Generic Core scores of ambulatory boys who were 
diagnosed recently and those who have been diagnosed for longer a period 
 Diagnosed after 2012 
(N=5) 
Diagnosed before 2012  
(N=51) 
Child report 
QoML Overall 80.9 (24.1) 79.8 (18.1) 
QoML Health 75.3 (31.2) 76.4 (20.8) 
PedsQL Generic Core Total 69.7 (7.3) 60.0 (14.6) 
PedsQL Generic Core 
Physical 
65.6 (7.0) 51.4 (20.5) 
PedsQL Generic Core 
Psychosocial 
72.1 (12.0) 64.6 (14.9) 
PedsQL Neuromuscular  81.42 (4.92) 73.2 (11.7) 
Parent report   
QoML Overall 76.1 (13.9) n=2 69.9 (18.6) 
QoML Health 76.8 (16.4) 67.9 (21.5) 
PedsQL Generic Core Total 54.6 (13.2) 54.3 (16.4) 
PedsQL Generic Core 
Physical 
40.8 (18.0) 47.5 (23.3) 
PedsQL Generic Core 
Psychosocial 
63.8 (11.1) 57.9 (15.4) 
PedsQL Neuromuscular  77.3 (12.9) 72.5 (13.2) 
PedsQL DMD 66.4 (16.7) 67.1 (15.9) 
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Table 4-10 QoML and PedsQL Generic Core 4.0 scores of non-ambulatory boys 
who lost ambulation recently and those who have been non-ambulant for a longer 
period 
 Lost ambulation after 2012 
(N=3) 
Lost ambulation before2012 
(N=20) 
Child report 
QoML Overall 69.3 (26.8) 80.12 (18.3) 
QoML Health 51.0 (40.3) 69.07 (25.6) 
PedsQL Generic Core Total 35.5 (6.7) 52.19 (14.2) 
PedsQL Generic Core 
Physical 
11.5 (9.3) 25.24 (19.6) 
PedsQL Generic Core 
Psychosocial 
48.3 (9.3) 66.88 (17.3) 
PedsQL Neuromuscular  50.0 (17.4) 73.24 (11.7) 
PedsQL DMD 48.6 (23.2) 62.01 (20.4) 
Parent report 
QoML overall 46. 4 (34.9) 71.79 (16.7) 
QoML health 40.7 (17.8) 72.89 (17.6) 
PedsQL generic core total 35.9 (15.3) 45.59 (14.3) 
PedsQL generic core 
physical 
31.3 (43.3) 32.31 (30.1) 
PedsQL generic core 
psychosocial 
38.3 (9.3) 54.09 (16.1) 
PedsQL Neuromuscular  37.3 (6.8) 53.63 (16.1) 
PedsQL DMD 35.2 (15.3) 48.32 (19.9) 
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Chapter 5  
                               Discussion 5
This chapter will provide interpretations of study findings and place them in the context 
of existing literature. Clinical and research implications of some results, as well as the 
strengths and limitations of the study are discussed. Finally, conclusions and potential 
future research avenues are presented. 
5.1 Summary of Results 
5.1.1 Describe the QOL and HRQOL of boys with DMD in Canada 
from both child and parent perspectives (Objective 1). 
When compared to children with rheumatoid arthritis and their parents, respectively, 
those with DMD and their parents reported poorer QOL and HRQOL (Feldman et al., 
2000). This was to be expected given DMD is a life limiting disease whereas rheumatoid 
arthritis is not usually viewed in that manner. For both DMD and rheumatoid 
populations, parents’ ratings were lower than children’s self-assessment, this difference 
was more pronounced in the DMD population in this study.  
Three measures from the PedsQL Inventory were used as multidimensional measures of 
HRQOL. The results in our sample were similar to those reported by others (McDonald 
et al., 2010; Uzark et al., 2012). From the generic measure, HRQOL was worse in boys 
with DMD than healthy children. The biggest difference was found in the physical 
domain. This is not surprising considering the hallmark of the disease is progressive 
muscle loss. This was also found to be the case by other studies (Baiardini et al., 2011; 
Bendixen et al., 2012; Bray et al., 2011; Davis et al., 2010; Elsenbruch et al., 2013; 
McDonald et al., 2010; Opstal et al., 2013; Uzark et al., 2012).  Within the psychosocial 
summary in the Generic Core module, the social domain was the most impacted, this was 
also in line with findings of other authors (Bendixen et al., 2012; Elsenbruch et al., 2013; 
Hu et al., 2013; Uzark et al., 2012). Furthermore, the social domain was also the only one 
out of the psychosocial domains that fell below the significantly impaired cut-off score, 
which was designated as one standard deviation below the population mean (Varni et al., 
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2003). It is likely that diminished social HRQOL in boys with DMD is partially due to 
their physical limitations, but social function could also be a reflection of the high level 
of cognitive deficits in this population, impacting the boys’ ability to communicate with 
others of similar age.  
Across all measures QOL and HRQOL, parents’ ratings tended to be lower than boys’ 
self-reports, which has been consistently observed across a number of paediatric chronic 
illnesses (Ingerski et al., 2010; Upton et al., 2008). There could be a number of 
explanations for this observation: children likely do not understand the long term 
implications of their disease to the same extent their parents do, may have adjusted to 
their disorder over time, or may have different concerns than their parents when it comes 
to factors that influence HRQOL or QOL. Parents may also let their own worries and fear 
about their child’s disease influence their assessment of their child’s HRQOL. 
Spinal muscular atrophy (SMA) is another type of paediatric neuromuscular illness, and 
is a good comparison group for DMD. Like DMD, SMA is characterized by progressive 
muscle weakness, however, muscular degeneration occurs at an earlier age and much 
more severely. On the other hand, children with SMA are not affected cognitively to the 
extent of boys with DMD. On the PedsQL 3.0 Neuromuscular module, both boys with 
DMD and their parents reported higher scores in “About my neuromuscular disease” 
domain, but lower scores in the “Communication” domain than children with SMA and 
their parents. This is consistent with the symptomology of the two diseases, there is a 
higher prevalence of cognitive disability in DMD which could further impact the boys’ 
ability to communicate and socialize with others (Cotton et al., 2001). Children with 
SMA are not impacted cognitively but have more severe physical symptoms (Iannaccone 
et al., 2009). In our sample, 51% of parents indicated their child with DMD has a 
developmental delay and/or learning disorder, and 10% of parents indicated their child 
has autism spectrum disorder, all of which could have a negative influence on the child’s 
communication skills. However, it should be noted that we did not directly measure the 
cognitive ability of our sample, and any relationship between cognitive ability and 
HRQOL is speculative. 
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Lastly, the more disease-specific PedsQL 3.0 Neuromuscular module was better at 
discriminating between boys with DMD and children with SMA than the Generic Core 
module, as the differences between the two groups were more pronounced on the 
Neuromuscular module than Generic Core module. This was to be expected for disease-
specific measures (Eiser & Morse, 2001a; Quittner et al., 2003), which are designed to be 
more sensitive to differences within a disease group. 
5.1.2 Examine the relationship between QOL and HRQOL 
(Objective 2). 
Single-item measures of QOL and HRQOL were rated as distinct but related concepts by 
both the boys with DMD and their parents. This was also found to be the case by 
Feldman et al. (2000), who found that in a group of children with rheumatoid arthritis, 
HRQOL explained 30% of the variability in QOL. In our sample, HRQOL explained 
21% and 44% of the variability in QOL in child- and parent-reported measures, 
respectively. Our results supported our hypothesis that boys with DMD and their parents 
consider QOL and HRQOL to be distinct but related concepts. QOL and HRQOL were 
significantly related to each other, but for both child and parent reports, over 50% of the 
variability in QOL were not explained by HRQOL. It is also likely that the association 
between these two single-item measures of QOL and HRQOL is partially due to 
common-method variance, specifically because of common scale format and anchoring 
(Snow et al., 2013). Thus, to further investigate the relationship between QOL and 
HRQOL, we also tested the association between the single-item QOL and a 
multidimensional HRQOL, the PedsQL 4.0 Generic Core module, and found that they 
were not significantly related to one another. However the lack of association between 
these two measures could be due to differences in their design - QOL is a single-item 
measure whereas the PedsQL 4.0 Generic Core module is a multidimensional measure. 
We investigated the relationship between two measures of HRQOL (one single-item and 
one multidimensional), and found they were significantly associated with one another. It 
appears that when asked to ‘consider their health’ on the QoML, boys with DMD and 
their parents considered aspects of the child’s life that are more or less aligned with 
domains measured by the multidimensional HRQOL. Whereas, when the respondents are 
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rating the broader, overall QOL, they may be thinking less about their health, or were 
considering aspects of their lives other than health-related domains. This theory is also 
supported by our and Feldman’s finding that HRQOL explained less than 50% of the 
variability in QOL. 
In the qualitative debriefing that took place during the development of the QoML, factors 
such as relationship with family and friends were identified, in addition to health, as 
being important in determining overall QOL (Feldman et al., 2000). People place 
different values on various aspects of their health and life, leading to different 
assessments of QOL in relation to HRQOL. Those lacking in health may have other 
aspects of their lives that ‘make up’ for that health deficit. Our results support the notion 
that QOL and HRQOL are regarded as related constructs by boys with DMD and their 
parents, and suggest there are factors outside of HRQOL that contribute to QOL.   
5.1.3 Explore child and family characteristics that contribute to any 
difference between QOL and HRQOL (Objective 3). 
On the QoML questionnaire, QOL and HRQOL were both measured on VAS scales. We 
explored factors that were associated with the difference between single-item measures of 
QOL and HRQOL. More specifically, we investigated child and family characteristics 
that could potentially contribute to boys with DMD and their parents rating QOL to be 
higher than HRQOL.  
For both child self and parent proxy-reports, no factors were found to be significantly 
associated with a respondent rating their QOL to be higher than HRQOL. However, the 
lack of significance is likely due lack of statistical power given the small sample size. By 
child report, children whose parents had post-secondary education were 5.2 times more 
likely to rate their QOL to be much higher than children whose parents did not have post-
secondary education, even though the relationship was not significant. Parental education 
has been found to be a factor significantly associated with child’s HRQOL in a group of 
children with sickle cell disease (Panepinto et al., 2005).   
We divided our sample into two groups: those who rated QOL to be much higher than 
HRQOL and those who did not. In the latter group, the heterogeneity is greater as we 
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grouped those who rated QOL to be slightly higher than, equal to, and lower than 
HRQOL together. The extent of heterogeneity could have reduced the power and 
contributed to the wide confidence intervals. 
5.1.4 Explore the association of child and family characteristics 
with multidimensional measures HRQOL (Objective 4). 
We explored child and family factors associated with multidimensional measure of 
HRQOL from the PedsQL Inventory. Due to the exploratory nature of our study, we did 
not anticipate any specific factor as a primary predictor of interest. Instead we used 
backwards elimination to elucidate a subset of variables that are associated with HRQOL 
which could inform future research. By both child and parent reports, the factor that was 
consistently associated with HRQOL was fatigue. Fatigue was associated with every 
HRQOL outcome, and in greater magnitude than other factors; boys and parents who 
reported greater fatigue reported worse HRQOL. Fatigue has not been examined closely 
in the DMD population, as far as we could determine from the literature. Thus, the strong 
relationship between fatigue and HRQOL came as an unexpected, but not an overly 
finding.  
Muscle fatigue is a physiological consequence of muscle degradation in DMD; decreased 
lung and heart function all could contribute to weakness and fatigued muscles (Angelini 
& Tasca, 2012). Fatigue can also be thought of as a subjective experience and measured 
as such. The PedsQL 3.0 Multidimensional Fatigue module was initially designed to 
measure fatigue in paediatric cancer patients and was found to be feasible, reliable and 
valid (Varni et al., 2002). It has also been validated in a variety of other chronic illnesses 
(Huang et al., 2013; Marcus et al., 2009; Meeske et al., 2004; Varni et al., 2004). Fatigue 
manifests itself both physically and mentally, and is multidimensional in nature. A 
confirmatory factor analysis supported the existence of three domains in the PedsQL 3.0 
Multidimensional Fatigue Scale: the general, sleep/rest and cognitive domains (Varni et 
al., 2013).  
Other studies have also reported associations between fatigue and poorer QOL or 
HRQOL in children with chronic illnesses. In a group of paediatric cancer survivors, 
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fatigue was the only factor significantly associated with both physical and psychological 
HRQOL (Meeske et al., 2007). Fatigue has consistently been identified as an important, 
if not the most important factor associated with HRQOL (Eddy & Cruz, 2007; Huang et 
al., 2013) in children with various chronic illnesses. 
Fatigue in neuromuscular disorders has been mostly studied in adults, and samples have, 
to our knowledge, not included DMD patients. Fatigue is a common complaint of adult 
patients with neuromuscular illnesses, it was reported by 60% of a cross-sectional sample 
of adults with common neuromuscular disorders (Kalkman et al., 2005). In other studies 
of adults with neuromuscular illness, fatigue was one of the factors associated with 
HRQOL (Burns et al., 2012; Oksuz et al., 2009). In a study of people with muscular 
dystrophies, pain and fatigue were found to be independently associated with lower 
physical function and greater depression (Alschuler et al., 2012).  
Because fatigue is such a common manifestation in neuromuscular illnesses, some 
neuromuscular disease-specific HRQOL measures contain a fatigue-related component. 
For example, the Individualized Neuromuscular QoL questionnaire for adults has a 
fatigue domain (Rose et al., 2012). In our study, it was noted that the PedsQL of fatigue 
module and the PedsQL Neuromuscular module share two of the questions, which 
renders them not completely independent from each other. However, given the strong 
significance in every other module, where there were no identical questions, we believe 
this is a robust finding.  We also examined whether there were any associations between 
fatigue and other clinical variables. By parent proxy-report, there were no significant 
associations between fatigue and any of the clinical variables such as age and FVC. In 
contrast, by child report, children who were using a wheelchair intermittent had 
significantly greater fatigue than children not using a wheelchair. Perhaps boys who are 
just transitioning into wheelchair use struggle with trying to maintain ambulation when 
they maybe too weak to do so. This is a well-recognized clinical issue often resulting in 
pain and falls. Taken together, fatigue was clearly a significant factor negatively 
impacting HRQOL of boys with DMD, and this is an important novel finding which 
potentially contributes to advancing research and improving clinical care for DMD 
patients. 
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Another factor consistently associated with HRQOL was wheelchair use. Boys who were 
in wheelchairs, had poorer HRQOL than boys not in wheelchairs across all HRQOL 
measures, with the exception of psychosocial summary score. The negative disease 
milestone of transition to full time wheelchair use is of particular focus to boys, their 
families and clinicians and so this finding is not surprising in the clinical context. This 
result is similar to other studies that found significant associations between clinical 
measures of strength and physical HRQOL, but not psychosocial HRQOL (Bray et al., 
2010, 2011; McDonald et al., 2010). These results suggest that while progression of 
DMD severely impacts physical aspects of a child’s life, it does not necessarily impact 
the emotional aspects of a child’s life, at least, not to the same degree as the physical 
aspect.  
Age was only associated with the PedsQL 3.0 Neuromuscular module, and no other 
HRQOL measures. This was a somewhat surprising result as age is often considered a 
proxy for disease severity and one would speculate that it would be associated with 
HRQOL. The fact that age did not remain significantly associated with most measures of 
HRQOL could be the result of adjusting for other factors such as wheelchair usage. In 
unadjusted analyses, by parent proxy-report, age was related to all measures of HRQOL; 
by child report, age was related to PedsQL 4.0 Generic core total and physical summary 
score, and the Neuromuscular module score. In other studies (Davis et al., 2010; Uzark et 
al., 2012), older boys with DMD had poorer physical HRQOL than younger boys, but not 
worse psychosocial HRQOL. 
Having at least one developmental or mental disorder was negatively associated with 
parents’ report of their child’s psychosocial HRQOL is consistent with other literature 
(Panepinto et al., 2005). A study of children with epilepsy also found that presence of 
cognitive problems was predictive of poorer HRQOL (Speechley et al., 2012).  
FVC appears to be a significant factor only in the PedsQL 3.0 DMD module is consistent 
with the physical manifestation of the disease. Loss of respiratory function is an 
important aspect of DMD, and its association with the DMD module highlights the 
sensitivity of the PedsQL 3.0 DMD module to the disease itself.   
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Due to the exploratory nature of our study, we used multivariable regressions where all 
the explanatory factors were treated as equals.  Alternatively, structural equation 
modelling, and more specifically, path analysis, would allow us to investigate the 
relationship between the explanatory variables in a more sophisticated manner and 
potentially establish a more causal relationship between these variables and the outcome. 
For example, a potential path could be that FVC or ambulation status affects fatigue 
level, which in turn affects HRQOL.   
5.1.5 Compare QOL and HRQOL of ambulant boys who were 
diagnosed recently to those who were diagnosed longer ago   
(Objective 5). 
We compared HRQOL of boys who were diagnosed more recently (after 2012) with 
those who had been diagnosed for longer (before 2012) but who were at the same plateau 
phase of the disease (i.e. who were still ambulant). During this phase, the health condition 
of these boys stays relatively constant. Thus we hypothesized that boys who were 
diagnosed more recently and their parents would report worse HRQOL than boys who 
have been diagnosed for longer who have had more to time to adjust to the diagnosis. 
This was not what we found. Within the ambulatory group, there were no differences in 
any of the HRQOL outcomes between boys who were diagnosed after 2012 and boys 
who had been diagnosed for longer. This did not support our hypothesis that the boys 
more recently diagnosed would have worse HRQOL, even on the psychosocial HRQOL. 
The fact our results did not support our hypothesis was not as surprising in child-report as 
it is for parent proxy reports. When these boys were diagnosed, they were very young and 
thus they may not have had the cognitive capacity to comprehend the impact of their 
disease and what their future holds. But for the parents this is often a devastating time 
and the clinical experience is that parents seem to be more affected, emotionally, than the 
child himself because parents are able to envision their child’s future and how DMD will 
impact it. It should also be noted that any interpretation of results must be done with 
caution as the samples sizes are small. It might also be worthwhile, in the future, to 
compare the HRQOL of parents whose boys were recently diagnosed to that of parents 
whose boys who had been diagnosed for longer.  
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5.1.6 Compare QOL and HRQOL of boys who lost ambulation 
recently to those who lost ambulation longer ago    
(Objective 6). 
Loss of ambulation is considered a major transition point in the course of DMD. In the 
non-ambulatory group, there were no statistically significant differences between boys 
who lost ambulation within the last year and boys who have been non-ambulant for 
longer than one year. However, the lack of significance could be due to small sample 
sizes, as there were only 3 boys who lost ambulation within the past year. The boys who 
lost ambulation over one year ago had much better HRQOL than boys who lost 
ambulation more recently, even though the differences were not significant. It seems that 
loss of ambulation is a particularly distressing event for the boys with DMD and their 
parents. This was found to be the case by Bray et al. (2011) who reported that parents of 
boys with DMD reported that their son’s transition to wheelchair had a very negative 
emotional impact, and that their emotional coping was disrupted at time of loss of 
ambulation. It is also possible that as time passes, there is some adjustment in the 
HRQOL after the first year as the child stays in the long period of non-ambulation 
plateau.  
5.2 Implications 
This study examined QOL and HRQOL in a sample of boys with DMD across Canada. It 
demonstrated the feasibility and some of the challenges of using a nation-wide registry, 
the CNDR, and mail-out questionnaires to conduct research studies. A national, clinic 
based registry is a valuable research tool for studies of this nature. The ability to engage a 
broad representative sample of patients from different clinics and regions is reassuring for 
generalizing the results to the larger DMD population. Further, the ability to use accurate 
data collected in the clinic confers more confidence in study results than patient driven 
web-based registries available in other countries. Of particular importance to the 
generalizability of patient reported outcomes such as QOL and HRQOL, is the ability to 
compare respondents to non-respondents and determine if any significant differences 
exist. A registry based study can provide this valuable information.  
72 
 
This study replicated previous findings that HRQOL in boys with DMD are poorer than 
that of healthy children, from both children’s and parents’ perspectives. Also in line with 
other studies, we found that the social aspect of HRQOL in boys with DMD are affected 
more than emotional and school aspects. Given this knowledge, efforts can be made to 
enhance the social HRQOL of boys with DMD. For example, these boys may participate 
in social skills training program to improve their abilities to interact with others. 
Furthermore, teachers and education assistants can develop programs and scenarios that 
encourage more seamless participation of boys with DMD alongside their typically 
developing classmates. Finally, school-based education programs may also be 
implemented to reduce stigma, improve knowledge and attitudes toward boys with DMD. 
Such programs have found success with epilepsy (Martiniuk et al., 2007).  
To our knowledge, this is the first study that explores the relationship between QOL and 
HRQOL in the DMD population, and one of very few studies that have addressed these 
concepts in the child health realm. The finding that QOL and HRQOL are distinct but 
related concepts corroborates the findings of Feldman et al. (2000). This finding 
emphasizes the need to recognize QOL as a more holistic representation of the child’s 
subjective experiences. Such recognition can help clinicians to more effectively guide 
families of boys with DMD in making disease management decisions that will have the 
most beneficial impact on the lives of these boys, not just their health. In addition, this 
finding highlights the importance of continued investigation into the relationship between 
QOL and HRQOL. For example, a qualitative study may be carried out where boys with 
DMD and their parents are asked how their ideas of QOL and HRQOL differ. 
Information from this type of study could drive further cross-sectional and longitudinal 
studies that include a more comprehensive dataset to better understand the contributions 
of various factors to QOL and HRQOL. 
This study identified fatigue as a potentially modifiable factor associated with a number 
of HRQOL outcomes, which was an unexplored concept in DMD. The formal assessment 
of fatigue has not been a focus of standard clinical care for children with DMD either, 
and our conclusions suggest that it warrants much more attention from clinicians. 
Modifying school and home schedule to ensure adequate rest, and improving sleep 
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hygiene could also lead to reduction of fatigue. The higher level of fatigue in boys who 
use wheelchair intermittent compared to those use wheelchairs full-time suggest that 
earlier initiation of full-time wheelchair use could reduce fatigue, and if families and 
clinicians are more aware of the impact on HRQOL then this may become a more 
palatable intervention. Other implications for clinicians arise from this study, placing 
increasing importance on understanding factors that contribute to fatigue. For example 
sleep apnea is a commonly reported problem in children with DMD (Polat et al., 2012) 
and contributes to daytime sleepiness and fatigue, perhaps earlier monitoring of sleep 
quality can be initiated to reduce fatigue. 
Even though this was a cross-sectional study, it supported the paradigm that loss of 
ambulation is an extremely stressful event. Perhaps in addition of providing the boys with 
DMD with wheelchair support, emotional support, such as referral to a counselor could 
also be provided. Anticipatory guidance about wheelchair is likely lacking currently in 
the clinics as so much of the focus is on preventing loss of ambulation, and real 
discussion and planning about wheelchair use is often neglected. The knowledge that 
HRQOL of boys who lost ambulation seem to be better in those who have been non-
ambulant for longer period of time, and that advancing age is not necessarily associated 
with a progressive decline of HRQOL, could also offer hope to children and parents who 
do not recognize that their HRQOL does not precipitously fall over time. 
The Food and Drug Administration has mandated that patient-reported outcomes such as 
QOL and HRQOL be included as endpoints of clinical trials. A number of promising 
therapies for DMD are in various stages of clinical trials. In order to be able to interpret 
these forthcoming results, minimally clinically important differences (MCID) need to be 
established to understand the magnitude of change that is meaningful to patients. MCIDs 
of QOL and HRQOL measures are important on their own, and they also help to establish 
clinical meaningfulness of other commonly used endpoints such as 6-Minute Walk Test 
through associating changes in these endpoints to changes in HRQOL outcomes.  Our 
study provided a profile of HRQOL at different stages and set the foundation for 
longitudinal studies in order to establish MCIDs.  
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Our identification of fatigue as a potential determinant of HRQOL suggests that perhaps 
fatigue could be measured alongside HRQOL in future clinical trials. Inclusion of fatigue 
measures would help us determine whether the treatment in question has an effect on 
fatigue as well as HRQOL.  Longitudinal study involving both fatigue and HRQOL 
measures would also establish magnitude of change in fatigue that corresponds with a 
meaningful change in HRQOL. Furthermore, since fatigue appears to be such an 
important factor associated with HRQOL in boys with DMD, and fatigue is a 
multidimensional measure, future research should explore specific aspects of fatigue that 
contribute most to HRQOL. Doing so would enable clinicians to target a specific aspect 
of fatigue (e.g. sleep/rest fatigue) that might have the biggest impact on improving 
HRQOL in boys with DMD. Finally, the relationship between fatigue and other clinical 
endpoints such as 6-Minute Walk Test and strength measures could be established in 
future studies to compare sensitivity of clinical endpoints to changes in disease severity 
Our study showed support for the notion that QOL and HRQOL are distinct but related 
concepts and we believe this finding could have implications for clinical trial outcomes. 
There is a theory that QOL tend to stay more stable than HRQOL over time (Cummins, 
1998), as people tend to maintain a state of homeostasis in their lives. Thus, in clinical 
trials, if we have both QOL and HRQOL measures, we would expect HRQOL may 
change more in response to the treatment. Having a measure of QOL could serve as a 
reference point, and help us better interpret changes in HRQOL.   
5.3 Strengths and Limitations 
There are several strengths of our study. This study offered one of the most 
comprehensive examinations of QOL and HRQOL in the pediatric DMD population to 
date. It was one of the first that used a national registry to recruit patients and thus is 
made up of a more representative sample than studies that recruited their participants 
from a single clinic. This study used a variety of measures that ranged from general to 
disease-specific and included both child self-report and parent proxy-report, to capture 
the most complete perspective possible. This study is the first to examine child and 
family factors associated with HRQOL via multivariable regressions. We identified a 
potentially modifiable clinical factor, fatigue that could lead to improvement of HRQOL 
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in this population. Finally, this was the first study that explored the relationship between 
QOL and HRQOL, providing empirical evidence for the distinction between these two 
concepts. 
This study also had a number of limitations. The cross-sectional nature of the study did 
not allow for causal relationships to be established. Also, the QoML measure has not 
been validated in the DMD population, nor has it been used, to our knowledge, in young 
children. A study found that only 42% of kindergarten aged children (5.0-6.8 years of 
age) were able to complete VAS scales satisfactorily on their own (Shields et al., 2003). 
In the young children group in our sample, 50% (N=13) of the QoML measures were not 
filled (returned blank). Of the young children who did complete the QoML measure, the 
majority had checked the box beside ‘this form with filled out by my parent’.  
Presumably, for these children, their answers were physically marked on the VAS by 
their parents. This brings forth another limitation, which is that due to the mail-out nature 
of our study, we cannot be sure of the extent to which parents ‘helped’ their boys 
completes their questionnaire. We had provided instructions for children and parents to 
complete their questionnaires independently, and if the child does require help with 
reading comprehension, that the parent does not influence their child’s answers. 
However, it is still possible that some parents had some influence over their child’s 
responses. One way of examining this potential issue is to compare the concordance 
between children and parents in our sample to studies where one can be sure children and 
parents completed HRQOL assessments independently. For example, some studies had 
their participants complete the questionnaires in clinics under the supervision of research 
assistants (Davis et al., 2010; Uzark et al., 2012). If the concordance in our sample is 
significantly higher than those of other studies, it might suggest that parents had ‘helped’ 
their children complete their questionnaires. Another potential limitation is the accuracy 
of the CNDR information. Registry updates are reliant upon individual clinics, and 
clinical information is supposed to be updated each time a patient visits clinic. Due to 
limited resources at some sites, not all patients have the most updated information. Thus, 
some of the clinical characteristics in our study, despite our best efforts, were out of date 
(e.g. FVC was more than a year old). However, the majority of the patients did have up-
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to-date information in the registry, particularly with regards to major disease milestones 
such as transition to intermittent and full-time wheelchair use. 
Lastly, our response rate of 56% is not ideal, generating a concern regarding the 
generalizability of our results. This concern is somewhat alleviated by the use of a 
registry to recruit participants, which allowed for their comparison to non-participants on 
a number of characteristics such as age and ambulation status. There were no statistically 
significant differences between the two groups in any of these characteristics, suggesting 
that our respondents are fairly similar to those who did not respond. However, as the non-
respondents were slightly older and more likely to have lost ambulation, it is possible that 
the non-respondents are at a more severe stage of the disease than boys who did respond. 
Therefore, it is possible that the QOL and HRQOL are somewhat overestimated in our 
sample, especially in the physical domain.  
A possible reason for our response rate could be related to our recruitment method. Per 
policies of the CNDR, we, as the study investigators, could not have direct contact with 
families who did not respond to our questionnaires. This lack of direct contact may have 
limited our response rate as it has been shown that contacting potential participants 
before sending the questionnaire and contacting non-respondents directly increased final 
response rates (Edwards, 2002).  
5.4 Conclusions and Future Work 
QOL and HRQOL of boys with DMD as judged by self-report and parent-report, are 
worse than the healthy population, and children with other types of chronic illnesses. 
Domains related to physical function were affected more than domains related to 
psychological and social functioning. It appears that QOL and HRQOL are related 
constructs, but there are factors outside of HRQOL that contribute to the QOL of boys 
with DMD. Further research is needed is to elucidate these factors. Fatigue has emerged 
as a clinically amendable factor associated with HRQOL and warrants further attention 
from clinicians and researchers. Lastly, it appears that loss of ambulation is particularly 
difficult event for the boys and their parents, but there is evidence that HRQOL 
potentially improves over time. 
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We are currently in the process of extending our cross-sectional project into a two-year 
longitudinal project and have already begun the process of collecting data for the second 
time point. We will be able to track temporal changes in QOL and HRQOL in our sample 
of boys with DMD, and be able to explore the relationship between QOL and HRQOL 
over time. Finally, we will be able to establish more causal relationships between 
potential determinants of HRQOL and HRQOL outcomes.  
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